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Chapter 1 
Introduction 
1.1 Intracellular signaling 
Cells dynamically control their internal response to a barrage of external 
signals using an intricate network of signaling pathways (Peifer, 1999). One 
mechanism is the regulation of protein phosphorylation levels (Evans and 
Hemmings, 1998). Another common mechanism moderates the lifetime, and 
spatial and temporal localization of protein complexes. Critical to these 
latter processes are ‘adaptor’ domains which bind specifically to other 
proteins, like discriminating glue. Proteins frequently contain multiple 
protein adaptor domains, each copy with unique ligand binding specificities, 
providing cells the ability to finely control internal protein association 
(Pawson and Nash, 2003). 
 
Several different adaptor domains that mediate signal transduction have 
been discovered. These include SH2, SH3, PH, PTB, LIM and PDZ 
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domains1 (Pawson and Scott, 1997; Pawson and Nash, 2003). Although 
these signaling domains are very dissimilar with respect to their structures 
and binding specificities, their modus operandi bears similarities. 
 
Most signaling domains recognize and bind distinct protein sequences of a 
4-5 residue length (Pawson and Nash, 2003). Some proteins pair signaling 
domains with catalytic domains such as phosphatase or kinase domains, thus 
regulating their internal phosphorylation levels (Evans and Hemmings, 
1998). Examples include proteins such as Src, PTP-BL, CASK and SAST. 
Other proteins are entirely composed of signaling domains joined by linkers 
(e.g. MUPP1, GRIP1, periaxin and harmonin); the function of these latter 
types of proteins is presumed to serve as a scaffold on which active protein 
complexes form. 
 
The interactions of one such signaling domain, the PDZ domain, has been 
well-described by structural studies (Fan and Zhang, 2002; van Ham and 
Hendriks, 2003). PDZ domains are between 80 and 100 residues in length 
and contain two α helices and six β strands folded into a compact structure 
(Chapter 2; Fan and Zhang, 2002). They bind C-terminal ligands by several 
conserved interactions. These include the insertion of the ultimate C-
terminal residue into a hydrophobic pocket, specific hydrogen bonding to 
the βB strand, plus various interactions involving the preceding ligand 
residues (Chapter 6; van Ham and Hendriks, 2003). PDZ domains are also 
                                                 
1
 Proteins and protein domains are referred to by their abbreviations.This practice 
is customary in molecular biology because proteins acquire names according to 
their origins of discovery, before their functions are fully known (Lawrence, 2003). 
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known to bind to internal protein segments, provided they are presented in a 
favorable structural motif (Hillier et al., 1999). 
 
This thesis focuses on the second PDZ domain in a protein named PTP-BL 
(protein tyrosine phosphatase BAS-like). PTPs are enzymes that remove 
phosphate groups from tyrosine residues within other proteins (Jackson and 
Denu, 2001). The attachment and removal of a phosphate group from a 
protein can have profound effects on a protein’s properties, for instance, a 
phosphate group can detrimentally affect protein association by introducing 
an electrostatic repulsion effect (Antz et al., 1999; Johnson and Lewis, 
2001). PTP-BAS was originally cloned in a human basophil cell line 
(Maekawa et al., 1994). The mouse version, which is the topic of this thesis, 
was given the name BAS-Like (PTP-BL) (Hendriks et al., 1995). 
1.2 Cellular role of the protein PTP-BL 
Expression 
PTP-BL is a large intracellular phosphatase with a molecular mass of 270 
kDa. It contains four types of structural domains: an N-terminal KIND 
domain, a FERM domain, common to membrane-cytoskeleton linker 
proteins, five PDZ domains (labeled PDZ1 to PDZ5), and a C-terminal 
phosphatase domain (Figure 1.1). 
 
 
Figure 1.1 A schematic diagram of the protein PTP-BL. PTP-BL is composed of four types 
of protein domains separated by linker regions (refer to the text). 
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The expression of PTP-BL is regulated during development (Hendriks et al., 
1995) and ranges from ubiquitous expression in the embryo to localized 
expression in epithelia and neurons in later developmental stages (Cuppen et 
al., 1998; Hendriks et al., 1995). Higher levels of PTP-BAS expression were 
shown to correlate with increased resistance to Fas-mediated apoptosis in 
several ovarian tumors (Meinhold-Heerlein et al., 2001). In addition, during 
development, the expression pattern of PTP-BAS is correlated with neurite 
outgrowth, suggesting a regulatory role involving the cytoskeleton during 
the development of the peripheral nervous system (Thomas et al., 1998). 
 
Subcellular Localization 
The PTP-BL protein contains internal regions that are homologous to 
several cortical proteins, including tumor supressors. In accordance, PTP-
BL exhibits a predominantly submembranous localization in epithelial cells.  
(Cuppen et al., 1998; Cuppen et al., 1999b). Fluorescence-recovery-after-
photobleaching (FRAP) experiments show that these PTP-BL-containing 
complexes at the cell cortex are dynamically formed and constantly 
reassembled (Cuppen et al., 1999b). In addition, PTP-BL has been reported 
to localize at the tips of cell extensions, in vesicles, in the Golgi apparatus 
and the nucleus (Cuppen et al., 1999a; Irie et al., 1999; Erdmann et al., 
2000; Ungefroren et al., 2001). PTP-BL has also been shown to accumulate 
in the axons and the growth cones of sympathetic and sensory neurons 
(Palmer et al., 2002; Thomas et al., 1998). In polarized epithelial cells, PTP-
BL is located apically (Cuppen et al., 1998) and this localization is 
determined by its FERM domain (Cuppen et al., 1999b). One splice variant 
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of PTP-BL accumulates at the centrosome and at the spindle midzone 
during cell division, and is part of the midbody in late cytokinesis 
(Herrmann et al., 2003). In summary, the localization of PTP-BL in 
different cell types is dependent on the cell type and culture conditions, 
probably reflecting the availability of proteins that interact with PTP-BL. 
The interaction characteristics of these protein domains are further described 
below. 
 
KIND domain 
The KIND domain is a recently discovered protein module with sequence 
homology to the C-lobe of protein kinases (Ciccarelli et al., 2003). 
Normally, the kinase C-lobe contains the catalytic residues that participate 
in transfer of a phosphate from ATP to a hydroxyl of a target protein. The 
KIND domain, however, lacks these catalytic residues and, in addition, is 
not linked to a kinase N-lobe, which contributes to the binding of ATP, thus 
making an enzymatic function unlikely. Given that the C-lobe normally 
mediates the interaction of kinases with other proteins, including substrates, 
the KIND domain is expected to facilitate protein-protein interactions 
(Ciccarelli et al., 2003). As of yet, no data are available for the role of this 
domain in the function of PTP-BL. 
 
FERM domain 
The FERM domain in PTP-BL is responsible for localization to the 
membrane side of epithelial cells (Cuppen et al., 1999b). It has been 
proposed that the FERM domain may interact with the phospholipid PIP2, 
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allowing signal-dependent cortical localization (Bompard et al., 2003); 
however, recent studies question the PIP2 binding capacity of this domain 
(Kimber et al., 2003). Alternatively, since the FERM domain of PTP-BL 
was found to co-sediment with filamentous actin, an interaction with the cell 
cortical actin meshwork may explain PTP-BL’s submembranous 
localization in epithelial cells (Herrmann et al., 2003). 
 
PDZ Domains 
Most efforts to elucidate the biological role of PTP-BL have resulted in 
identifying binding partners for its five PDZ domains. PDZ domains are 
modules that bind the C-termini of target proteins and orchestrate the 
formation of multi-protein complexes (van Ham and Hendriks, 2003). The 
PDZ domains of PTP-BL and its human orthologue PTP-BAS have been 
shown to interact with several proteins.  
 
PDZ1 interacts with the C-terminus of BP75 (Cuppen et al., 1999a), the 
proteins TAPP1 and TAPP2 (Kimber et al., 2003), and also with the ankyrin 
repeats of IκBα (Maekawa et al., 1999). Both PDZ2 and PDZ4 interact with 
TRIP-6 (Cuppen et al., 2000; Murthy et al., 1999), RIL (Cuppen et al., 
1998) and the human Fas Receptor (Sato et al., 1995; Cuppen et al., 1997). 
PDZ2 interacts with APC (Erdmann et al., 2000), RA-GEF-2 (Kozlov et al., 
2002) and p75NTR (Irie et al., 1999). PDZ3 binds to PRK2 (Gross et al., 
2001), and PDZ4 binds to ephrinB1 (Palmer et al., 2002), CRIP2 (van Ham 
et al., 2003) and the rhoGAP protein PARG (Saras et al., 1997b). No 
proteins are known to interact with PDZ5, although along with the PDZ2 
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and PDZ3 domains, PDZ5 is capable of interacting with the phospholipid 
PIP2 (Zimmermann et al., 2002). This lipid competes with C-terminal 
ligands for binding and it was suggested that PTP-BL might also have a 
function as a lipid transporter (Kachel et al., 2003).  
 
Phosphatase Domain 
The dephosphorylation ability of PTP-BL is limited in vivo by its highly 
restricted subcellular compartmentalization, which in turn is determined by 
the interactions of the above mentioned KIND, FERM and PDZ domains 
(Cuppen et al., 1999b). The existence of this microenvironment is 
demonstrated by the limited number of in vivo substrates that have thus far 
been associated with the phosphatase activity of PTP-BL, namely the 
proteins RIL, IκBα, and ephrinB (Cuppen et al., 1998; Maekawa et al., 
1999; Palmer et al., 2002). In addition, PTP-BL has also been shown 
capable of dephosphorylating the proteins c-src and β-catenin in vitro 
(Erdmann et al., 2000). 
 
Summary of Interactions 
It is clear from these many studies that PTP-BL can interact with a 
multitude of proteins; however, the functional implications of these 
interactions have yet to be organized in a coherent scheme. Possible 
functional roles have been postulated to include the regulation of Fas-
mediated apoptosis, ephrinB receptor signaling and the cytoskeletal 
rearrangements occurring during cytokinesis and neurite outgrowth. 
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PTP-BL has been implicated in mediating resistance to Fas-induced 
apoptosis (naturally occurring cell death) and may contribute to 
tumorigenesis by increasing cell survival (Sato et al., 1995; Itoh and Nagata, 
1993; Saras et al., 1997a; Bompard et al., 2002). It has been suggested that 
this increase in cellular survival is effected by the regulation of the surface 
expression of the Fas receptor (Ungefroren et al., 2001; Ivanov et al., 2003) 
or its phosphorylation status (Sato et al., 1995). 
 
The fourth PDZ domain in PTP-BL interacts with ephrinB1 (Palmer et al., 
2002), a receptor tyrosine kinase that regulates a wide variety of cellular 
processes, many of which ultimately involve the cytoskeleton. These 
processes include vascular development, tissue border formation, cell 
migration, axon guidance and synaptic plasticity (Wilkinson, 2001; 
Kullander and Klein, 2002). The proposed mechanism by which PTP-BL 
regulates the ephrin signaling pathways involves the recruitment of PTP-BL 
to ephrinB membrane clusters, dephosphorylating ephrinB, and thereby 
effecting a PDZ domain-dependent signaling mechanism (Palmer et al., 
2002). 
 
PTP-BL has been shown to be involved in cytokinesis, or cell division, a 
process that is governed the movements of microtubules and F-actin 
(Glotzer, 2001). During cytokinesis, PTP-BL was found to localize 
primarily at the junction between the two separating cells, at the midzone 
during anaphase and in the midbody at the end of cytokinesis (Herrmann et 
al., 2003). A functional role of PTP-BL in these processes is derived from 
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the observation that the overexpression of catalytically inactive PTP-BL in 
HeLa cells leads to defective cell-splitting in cytokinesis, finally resulting in 
multinucleate cells (Herrmann et al., 2003). The associations of PTP-BL 
with PARG, PRK2 and RIL point even more to a direct role in actin-
cytoskeleton dynamics. PARG is a Rho-specific GTPase-activating protein 
(Saras et al., 1997b) and PRK2 is a Rho regulated protein kinase (Gross et 
al., 2001). The Rho family of G-proteins consists of essential players in 
most actin-cytoskeletal rearrangments (Raftopoulou and Hall, 2004; 
Etienne-Manneville and Hall, 2002). Recently, RIL was further shown to 
modulate actin stress fiber turnover in osteosarcoma cells (Vallenius et al., 
2004). 
 
A gene trap insertion study investigated the localization and expression of a 
PTP-BL/β-galactosidase protein chimera in mice. This chimera exhibited 
strong expression patterns in epithelial cells and in nerve outgrowths, 
including growth cones. In particular, these last results suggest that PTP-BL 
may have a role in regulating the cytoskeletal remodeling involved in 
neurite outgrowth during the development of the peripheral nervous system 
(Thomas et al., 1998). 
 
In summary, it is likely that the dephosphorylation capacity of PTP-BL is 
recruited by processes involving cytoskeletal dynamics and the intracellular 
confinement of PTP-BL is determined by the interactions of its signaling 
domains. Indeed, the cellular overexpression of the catalytic, 
phosphotyrosine phosphatase domain of PTP-BL in the absence of its 
20   Chapter 1 
interaction domains results in striking morphological effects (Cuppen et al., 
1999b). An additional factor determining the function of PTP-BL is the 
specific expression and intracellular localization of its four splice variants 
(see Chapter 3). In conclusion, more studies are needed to construct a 
comprehensive scheme describing the intricate role of PTP-BL in 
intracellular signaling networks. 
1.3 PDZ domains in signal transduction 
PDZ domains have diverse binding properties resulting from the variability 
of their primary sequences and structural adaptability of their fold. Their 
binding preferences range from binding a -TEFCACOOH C-terminal 
sequence, like the PDZ domain in the INAD protein does, to binding the 
completely different -KQTSVCOOH sequence as the PDZ3(PSD-95) domain 
does (Kimple et al., 2001; Doyle et al., 1996). These differences in 
selectivity are important in forming unique protein complexes in diverse 
signaling pathways. In addition, it is often described that individual PDZ 
domains bind to several sequentially related C-terminal ligands. PDZ 
domains are currently classified into three or four categories according to 
their consensus ligands, as determined from the screening of peptide 
libraries (Songyang et al., 1997; Vaccaro and Dente, 2002). 
 
Errors in PDZ interactions can cause disease 
PDZ motifs play a central role in organizing protein complexes (Fan and 
Zhang, 2002; van Ham and Hendriks, 2003; Garner et al., 2000; Harris and 
Lim, 2001). Errors in PDZ-ligand recognition have been linked with several 
hereditary human diseases, including Usher syndrome, Fraser syndrome as 
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well as forms of hereditary demyelinating neuropathy and familial 
hypercholanemia. 
 
People with Usher syndrome have both significant hearing impairment and 
a progressive loss of vision. The underlying cause of the most severe type of 
usher syndrome (USH1) has been traced back to the misformation of a 
complex in the inner ear (Ahmed et al., 2003). A mutation in the C-terminus 
of cadhedrin 23 (-VSEVCOOH → -DSEVCOOH) changes its affinity for the 
first PDZ domain of harmonin, resulting in both significant hearing 
impairment and a progressive loss of vision (Siemens et al., 2002). 
 
Fraser syndrome is a genetic disease which is characterized by the partial 
webbing of fingers and toes, lack of eyelids and abnormal genitalia. In five 
different Fraser syndrome families, mutations in the FRAS1 gene have been 
identified, and an animal model for the disease is provided by the ‘blebbed’ 
(bl) mouse that carries a Fras1 truncating mutation (McGregor et al., 2003). 
The Fras1 protein resides on the cell surface, anchored by a transmembrane 
region and a short intracellular domain. Recently, it was found that mice 
lacking the multi-PDZ domain-containing protein GRIP1 also display a 
‘blebbed’ phenotype and that the interaction of GRIP1 with the C-terminus 
of Fras1 acts to retain it on the basal surface of epidermal cells (Takamiya et 
al., 2004). 
 
Demyelinating neuropathy is characterized by enlarged nerves, abnormal 
thickening of myelin sheaths, wasting of muscles as well as pain and 
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sensitivity in extremities (Boerkoel et al., 2001; Guilbot et al., 2001). 
Patients who either completely lack or express truncated versions of the 
PDZ-domain containing protein Periaxin display hereditary forms of 
demyelinating neuropathy. Indeed, it was shown that a mouse model lacking 
the Periaxin protein exhibits late-onset peripheral demyelinating neuropathy 
(Gillespie et al., 2000). The expression levels of Periaxin correlate with the 
severity of certain forms of this disease. Patients who produce truncated 
forms of Periaxin exhibit milder motor neuropathy while those who lack 
detectable levels of Periaxin possess more prominent sensory neuropathies 
(Takashima et al., 2002).  
 
Familial hypercholanemia (FHC) is characterized by elevated serum bile 
acid concentarion, itching and fat malaborption (Morton et al., 2000; 
Shneider et al., 1997). One of the genetic causes of FHC is associated with a 
Val→Ala mutation in the first PDZ domain of the in the tight junction 
protein ZO-2, a MAGUK protein. The Val→Ala substitution occurs in the 
third position of the βB strand, βB3, adjacent to the PDZ binding pocket 
(see Chapter 6 for further detail on PDZ domain alignments). This residue 
known to be critical to the structural integrity of the PDZ domain and 
extensively contacts bound ligands. Correspondingly, it was observed that 
this mutation reduces the stability and ligand binding ability of the first PDZ 
domain, and that this has both morphological consequences on the hepatic 
tight junctions and functional consequences for the circulation and 
transportation of bile acid (Carlton et al., 2003). 
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In summary, it is evident that PDZ domain-mediated interactions are often 
crucial in establishing proper assembly and localization of protein 
complexes. Consequently, changes that affect the affinity of PDZ-ligand 
interactions or disrupt the structure of PDZ domains can have deleterious 
biological consequences.  
1.4 Overview of NMR 
Most of the work reported in this thesis employed a technique called NMR 
(Nuclear Magnetic Resonance). To the uninitiated, an NMR machine can be 
thought of as a very large microscope where a high-powered magnet 
replaces the optical lens. Like a lens magnifies objects, the high magnetic 
field of the NMR machine allows researchers to ‘map out’ objects at the 
atomic level2. In reality, the truth is much more complex, as NMR relies on 
manipulating spin, a fundamental property of particles just like mass and 
electric charge. The theory that describes how electromagnetic radiation 
interacts with the magnetic moment that is inherently associated with spin 
has been thoroughly treated in several introductory text books (Levitt, 2001; 
Cavanagh et al., 1996). For all practical purposes, however, it is easiest to 
describe NMR in terms of its similarity to the medical technique of MRI 
(Magnetic Resonance Imaging). Most people are familiar with the use of 
MRI by doctors to map the bodies of patients, for example in preparation for 
a surgery (Figure 1.2).  
 
                                                 
2
The basic level at which NMR is treated in this chapter might annoy the 
specialists. The purpose of this introduction is to help non-specialists place 
biological NMR into a proper perspective. 
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Figure 1.2. Two 2D MRI scans of the head of the author. (A) Side view and (B) top view. 
Courtesy of Co de Haan. 
 
Both MRI and NMR use magnets to induce the polarization that is detected 
in the experiment. The first difference is the strength of the magnet. MRI 
magnets typically operate at strengths less than 8 Tesla while NMR magnets 
can reach strengths of 21.4 Tesla. The second difference is functional. 
Whereas MRI provides spatial images of body tissues by detecting the 
hydrogen atoms of water molecules, NMR visualizes molecules by 
detecting the properties of many types of atoms in diverse molecules. For 
biological NMR, these atoms typically include hydrogen, carbon, nitrogen, 
phosphorus and fluorine. The resolution of the two techniques also differs. 
MRI spatially resolves tissues to an accuracy of millimeters whereas the 
molecular structures that result from biomolecular NMR experiments are 
solved to accuracies at the atomic level (Å). 
 
A pictorial description of how researchers use the NMR experiment is 
displayed in Figure 1.3. After placing a test sample inside the NMR magnet, 
the strong magnetic field induces a net internal magnetization (M) of the 
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atoms in the sample (represented by the vertical vector in Figure 1.3). The 
researcher then manipulates M with a second, smaller transient magnetic 
field by applying a short burst of electromagnetic radiation in the radio-
frequency (RF) range. This transient magnetic field disturbs the system in a 
controlled way, flipping the magnetization vector away from the default 
vertical position to some other desired angle. Once this desired angle is 
reached, the RF is turned off. As the magnetization vector relaxes back to 
the default state, its fluctuations produce an electrical current in the 
detectors. This raw data is called the free induction decay (FID). A 
mathematical procedure called a Fourier transform (FT) is then used to 
convert the time-dependent FID into frequency-dependent spectrum. For 
biomolecules, the end result is a complicated NMR spectrum, with each 
NMR-active atom represented by a unique peak. For example, a typical 
protein of 100 amino acids in length contains over ~700 hydrogen atoms. 
Figure 1.3. How NMR works. The steady state of a sample is perturbed.  
The relaxation of the sample back to the steady state is recorded, and then mathematically 
converted into a useable spectrum. 
 
The protein spectrum on the right side of Figure 1.3 shows that each type of 
atom has a characteristic position, called the chemical shift. For instance, 
hydrogen atoms attached to either carbon (H-C) or nitrogen atoms (H-N) 
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appear in distinct regions of the spectrum. To increase the signal-to-noise 
ratio, stronger magnets, in combination with samples enriched with 
inherently magnetic nuclei, are used to increase the sensitivity of the NMR 
experiments. 
 
Contrasting protein structures solved by X-ray crystallography and NMR 
The structures of biomolecules are currently solved by the ‘competing’ 
techniques of solution NMR and X-ray crystallography. Crystal structures 
are solved from refraction patterns resulting from X-rays beamed through 
solid protein crystals, while NMR structures are solved from distance and 
angular data measured under more natural solution conditions. Each of these 
techniques is well-described in classic textbooks (Branden and Tooze, 1999; 
Lesk, 2001) and also offers its own advantages to structure determination, 
the highlights of which are described below. 
 
X-ray crystal structures are not characteristically limited by molecule size 
and their spatial resolution is generally higher. X-ray crystallography is, 
however, limited by the ability of a protein to crystallize, which for some 
proteins, such as membrane proteins and proteins with highly flexible 
regions, is notoriously difficult. X-ray structures do not usually have enough 
resolution to detect protons, which are key players in catalytic reactions and 
hydrogen-bonding networks. In contrast, NMR data provide the relative 
positions of many (but not all) hydrogen atoms.  
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As already mentioned, NMR determines structures of proteins in solution, 
but this technique is limited to soluble molecules not much greater than 30 
kD at present. NMR is the method of choice for small proteins which are not 
readily crystallized. One powerful aspect of NMR is the ability to quantify 
the dynamic mobility of each residue. In X-ray crystallography, flexibility 
merely results in a localized structural ambiguity, even sometimes rendering 
residues invisible, due to the low and nearly uniform electron density. 
1.5 Perspective on biomolecular NMR 
The advances in NMR research in recent years have allowed possibilities 
that were only dreamed of when the technique was first invented. These 
advances in NMR have been heralded by two Nobel prizes, the first of 
which was awarded to Prof. Richard Ernst (1991) for developing Fourier 
transform NMR and multiple-dimensional spectroscopy, both of which were 
fundamental to current day experimental design and greatly increasing the 
sensitivity by signal averaging and speed of data acquisition. The second 
Nobel Prize was awarded to Prof. Kurt Wüthrich (2002) for pioneering the 
techniques and concepts required to determine the three-dimensional 
structures of biological macromolecules in solution. 
 
Unlike other types of spectroscopy, the quantum-mechanical theory 
underlying NMR spectroscopy allows a thorough mathematical description 
which enables NMR spectroscopists to predict the results of an experiment 
before actually performing measurements (van de Ven and Hilbers, 1983; 
Sørensen et al., 1983). This powerful attribute has been critical in the 
invention of many complicated experimental schemes involving multiple 
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nuclei (for review, see Gardner and Kay, 1998). Biochemical isotope 
labeling techniques have also proved to be essential in the successful 
application of the complicated experiments. The result of these 
technological advancements has been a steady increase in the size of the 
biomolecules amenable to high-resolution NMR. Most recently, TROSY-
type experiments (transverse relaxation-optimized spectroscopy) have 
increased the sensitivity and resolution of larger biomolecules such that 
NMR spectra have been reported for a ~900 kDa protein complex (Fiaux et 
al., 2002; Pervushin et al., 1997). Other recent developments in protein 
NMR spectroscopy have also proved critical to structure determination, 
such as the detection of long range structural parameters like residual 
dipolar couplings (Chapter 6; Tjandra et al., 1997). In addition, a need for 
the quality assessment and standardization of biological structures 
determined by NMR has recently been emphasized (Chapter 2; Spronk et 
al., 2002). In general, these advances have been essential to complete the 
work described in this thesis. 
1.6 Scope and rationale of this thesis 
The goal of this project was to examine the interactions mediated by PDZ 
domains of the PTP-BL protein, in particular with the RIL protein. RIL 
contains one PDZ and one LIM domain joined by a linker region. It was 
reported that in a yeast protein interaction test system, the second PDZ 
domain (PDZ2) of PTP-BL bound strongly to the LIM domain of RIL, and 
that this binding appeared to be independent of the C-terminus (Cuppen et 
al., 1998).  
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As a first step, we solved the structure of the PDZ2 of PTP-BL. These data, 
along with the results from interactions with three different C-terminal 
peptides are reported in Chapter 2. A survey of the interactions of PDZ2 
with two additional ligands is described in Chapter 4. In 2000 it was 
reported that an alternatively spliced variant of PDZ2 (PDZ2as) had altered 
binding properties (Erdmann et al., 2000), prompting us to determine the 
structure of this PDZ2as domain; these results are reported in Chapter 3. 
The interactions of PDZ2 with the recombinant RIL-LIM domain, both 
including and lacking the C-terminus proper, are described in Chapter 5. 
The interaction characteristics of the complex of PDZ2 with the APC  
C-terminal ligand were determined by solving the structure of this complex. 
These results are reported in Chapter 6 and are compared to the data 
obtained for the PDZ2-RIL complex. Chapter 6 also summarizes the results 
from interaction studies reported in Chapters 2, 3, and 4, and uses these 
results to postulate a new system of classification of PDZ domain 
interactions. 
 
  
 
Chapter 2 
Structure, dynamics and binding characteristics of the second 
PDZ domain of PTP-BL.1 
Summary 
The PDZ domains of the protein tyrosine phosphatase PTP-BL 
mediate cell signaling processes by binding to specific amino acid 
sequences in target proteins. The solution structure of the second 
PDZ domain of PTP-BL, PDZ2, displays a compact fold with 6 β 
strands and two α helices. A unique feature of this domain compared 
to the canonical PDZ fold is an extended, flexible loop at the base of 
the binding pocket, termed L1, that folds back onto the protein 
backbone. The structure of PDZ2 differs significantly from the 
orthologous human structure. A comparison of structural quality 
indicators clearly demonstrates that the PDZ2 ensemble is 
statistically more reasonable than that of the human orthologue. The 
analysis of 15N-relaxation data for PDZ2 shows a normal pattern, 
with more rigid secondary structures and more flexible loop 
structures. Close to the binding pocket, Leu 85 and Thr 88 display 
greater mobility when compared to surrounding residues. Peptide 
                                                 
1 Walma T, Spronk CAEM, Tessari M, Aelen J, Schepens J, Hendriks W, and 
Vuister GW. (2002). J. Mol. Biol. 316, 1101-1110. 
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binding studies demonstrated a lack of interaction between mouse 
PDZ2 and the C-terminus of the mouse Fas/CD95 receptor, 
suggesting that the Fas/CD95 receptor is not an in vivo target for 
PDZ2. In addition, PDZ2 specifically binds the C-termini of both 
human Fas/CD95 receptor and the RIL protein, despite RIL 
containing a non-canonical PDZ-interacting sequence of -ExVCOOH. 
A model of PDZ2 with the RIL peptide reveals that the PDZ2 
binding pocket is able to accommodate the bulkier sidechain of 
glutamic acid while maintaining crucial protein to peptide hydrogen 
bond interactions. 
2.1 Introduction 
PTP-BL is a 270 kD mouse protein tyrosine phosphatase that contains an N-
terminal domain that lacks homology to other protein types, a KIND 
domain, FERM domain, five PDZ domains (denoted PDZ1 through PDZ5) 
and a C-terminal catalytic phosphatase domain (Hendriks et al., 1995). 
Localization studies have placed PTP-BL in the submembranous region of 
epithelial cells (Cuppen et al., 1998); however, the identities of its in vivo 
substrates have not been conclusively identified. Several candidate proteins 
have been identified on the basis of their association with the PDZ domains 
of PTP-BL (Figure 2.1). In particular, PDZ2 and PDZ4 interact with two 
LIM domain-containing proteins, RIL and TRIP-6 (Cuppen et al., 2000), 
which are found at actin-rich structures in the cell. In addition, human PDZ1 
can interact with BP75 (Cuppen et al., 1999), PDZ2 with the tumor 
suppressor protein APC (Erdmann et al., 2000) and PDZ3 with the Rho 
effector kinase PRK2 (Gross et al., 2001). 
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For the human orthologue of PTP-BL, PTP-BAS (also known as PTPL1, 
FAP-1, PTP1E, or PTPN13), a wide variety of PDZ-interaction partners 
have also been identified. Considerable interest in the literature has been 
shown in the reported interactions of PDZ2 and PDZ4 with the Fas/CD95 
receptor (Sato et al., 1995; Saras et al., 1997a), an interaction that does not 
seem to be conserved in mouse (Cuppen et al., 1997). In addition, PDZ1 has 
been reported to interact with IκBα (Maekawa et al., 1999), PDZ2 with 
p75NTR (Irie et al., 1999), PDZ4 with the Rho-GAP PARG1 (Saras et al., 
1997b) and with ephrinB (Lin et al., 1999). Although the physiological 
relevance for the observed interactions is still under study, current data 
indicate that PTP-BL/PTP-BAS plays a role in the organization of the cell 
cortical actin cytoskeleton, and perhaps in Fas-mediated apoptosis of human 
cells. The mechanism by which the PDZ domains of PTP-BL and PTP-BAS 
mediate such interactions requires further elucidation. 
 
Many PDZ domain-containing proteins interact with transmembrane 
proteins such as receptors and channels, or membrane-associated proteins. 
 
Figure 2.1. Schematic outline of some reported intracellular interactions involving PTP-
BL 
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Four types of interaction involving PDZ motifs have previously been 
described in detail. Class 1 interactions involve protein C-termini with a  
-ψxΦ* sequence motif (where Φ is refers to hydrophobic amino acids, ψ 
represents hydrophilic amino acids and * is the terminal carboxylate group) 
(Songyang et al., 1997). Examples of this interaction include DglA 
(Songyang et al., 1997), PSD-95 (Brenman et al., 1996) and NHERF 
(Karthikeyan et al., 2001). Class 2 interactions involve C-termini containing 
a -ΦxΦ* sequence motif (Songyang et al., 1997), behavior exhibited by 
CASK (Daniels et al., 1998) and INAD (van Huizen et al., 1998). The third 
type of interaction involves -E/DxΦ* sequences, for example, the nNOS 
PDZ domain binds -G-(D/E)xV* sequences (Schepens et al., 1997), a 
modification of the Class 1 requirements. The fourth class involves binding 
to -VxD/E* sequences (Vaccaro and Dente, 2002). An additional type of 
interaction involves PDZ binding to an internal -ψxΦ- sequence motif, as 
exhibited by the PDZ-PDZ dimerization interaction between syntrophin and 
nNOS (Hillier et al., 1999). 
 
PDZ domains adopt an α/β fold consisting of a partly open barrel formed by 
six β strands, termed βA to βF, and capped by two α helices, termed αA 
and αB. Ligand proteins bind to PDZ domains via a binding pocket located 
between βB and αB, creating an extension to the existing β sheet. Crucial 
PDZ-ligand interactions include backbone hydrogen bonds between βB and 
the ligand, interactions between the ‘carboxylate binding loop’ (located 
between the βA and βB strands) and the inserted carboxylate terminus, and 
finally sidechain charge and steric requirements for the P0 (or C-terminal) 
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and P–2 residues of the ligand protein. The structural basis for other reported 
PDZ interactions are unknown, most notably interactions of PDZ domains 
with ankyrin repeats (Maekawa et al., 1999) and LIM domains (Cuppen et 
al., 1998). For example, using a two-hybrid interaction trap, Cuppen et al. 
(Cuppen et al., 1998) showed that the interaction between PDZ2 and RIL-
LIM required the complete LIM domain, exclusive of the final four or 
twenty-one RIL C-terminal residues, and that binding of the PDZ2 to the C-
terminus alone was not detectable. These observations suggest a mechanism 
distinct from canonical PDZ interactions. Two possible explanations for this 
PDZ/LIM interaction can be envisioned. It could involve binding an internal 
sequence, analogous to the syntrophin/nNOS interaction, or it could involve 
a yet undiscovered binding surface on the PDZ and/or LIM domain. The 
latter hypothesis is supported by the discovery that PDZ scaffolding 
interactions are crucial in forming a ternary complex between PSD-95, 
nNOS and NMDA, and that the two binding faces of the PDZ domain of 
nNOS are capable of functioning simultaneously (Christopherson et al., 
1999). 
 
It has become clear that the mechanisms of PDZ–ligand binding are more 
diverse than previously thought. Therefore, we present here the structure 
and dynamics of the second PDZ domain of PTP-BL and its interactions 
with Fas receptor and RIL protein C-termini. Our results provide additional 
data on the binding preferences of PDZ2 and putative in vivo binding 
partners of PTP-BL. 
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2.2 Results 
Using high-resolution heteronuclear NMR spectroscopy, as outlined in the 
Experimental Procedures section, we calculated an ensemble of 35 high-
resolution NMR structures of the PDZ2 domain of PTP-BL, comprising 
residues 1351 to 1444 (corresponding to the 9 through 102 numbering 
convention of our protein). A stereo-view of the best superimposition of this 
ensemble is shown in Figure 2.2A. The structural ensemble was statistically 
analyzed using the programs PROCHECK-NMR (Laskowski et al., 1996) 
and WHAT-IF (Vriend, 1990); statistics for the ensemble are reported in the 
first column of Table 2.1 (The second column of Table 2.1 contains 
corresponding statistics for the human orthologue of PDZ2, vide infra). The 
pairwise RMSD of ordered backbone heavy atoms is 0.52 ± 0.09 Å, 
indicating a well-defined ensemble. The pairwise RMSD of the global 
backbone heavy atoms gives a larger value of 1.39 ± 0.36 Å. The 
Ramachandran plot displays 85% of the residues in most favored regions 
and 13% in additionally allowed regions. The RMS deviation from idealized 
covalent geometry Z-score values are close to unity, indicating that the 
ensemble exhibits good covalent geometry; these parameters are often weak 
points of NMR structures. 
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Figure 2.2. Structural Ensemble and Alignment of PDZ2. 
(A) Structural Ensemble of 35 PDZ2 structures (stereo-diagram).  
(B) Sequence alignment of PDZ2 with PDZ domains from PTP-BAS, DlgA, CASK and 
syntrophin. PDZ2 and its human orthologue possess an extended loop L1. Secondary 
structures of PDZ2 are indicated by bold. Regions that are structurally conserved with 
respect to PDZ2 (as calculated by WHAT-IF (Vriend, 1990)) are shaded gray. Boxes 
surround regions that are structurally conserved across all three class representatives and 
contain residues that were used in RMSD comparisons.  
 
The ensemble displays a compact fold with six β strands, βA through βF 
and two α helices, αA and αB (Figure 2.2A). In addition the structure 
contains five β turns and one flexible loop (L1) located between βB and βC. 
Based on relaxation data, the most flexible regions are the first β turn, in the 
loop L1 and the unstructured C-terminus (vide infra). The L1 loop of PDZ2 
(and its human orthologue) is distinct from other known PDZ domains, and 
consists an insert of 3 to 5 residues in comparison to other PDZ domains. 
Located near the binding pocket, this loop curves back onto the backbone, 
its conformation defined by distinct NOE contacts between Val 37 and Tyr 
43. The loop is also flanked by two sets of glycine residues (Gly 31/32 and 
Gly 40/41) that appear to act as hinges; the loop residues themselves 
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superimpose well (not shown). The N-terminal section of the loop, located 
directly under the binding pocket, is more structurally defined than the C-
terminal half, mainly because of contacts to αB. This loop is subject to 
alternative splicing that has been shown to affect binding to the APC C-
terminus (Erdmann et al., 2000). 
 
Structural Superposition of PDZ Domains 
To further analyze the structure, we superposed PDZ2 with four other PDZ 
structures, the human orthologue of PDZ2 from PTP-BAS (PDB entry 
3PDZ), and three representative X-ray structures from each of the known 
interaction classes: DlgA, CASK and syntrophin (PDB entries 1PDR, 
1KWA and 1QAV, respectively). PDZ2 shares the highest sequence identity 
with PTP-BAS (94% identity). The Class 1 type is represented by the X-ray 
structure of the third PDZ domain of human DlgA. This domain shares a 
34% sequence identity with PDZ2. The X-ray structure of the PDZ domain 
of CASK represents the Class 2 domain, sharing 28% identity. The X-ray 
structure of the PDZ domain of mouse syntrophin, with 39% identity; this 
domain has been shown to bind nNOS via an internal β-hairpin loop, the 
third type of interaction.  
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Table 2.1. Reported structural statistics for PDZ2 of PTP-BL and its human orthologue. 
Structural Statistics PDZ2 Human Orthologuea 
Restraint Informationb 
Distance Restraints  
 (intra-residual/sequential/medium/long) 
 
1489 
(515/356/185/433) 
 
1261 
(348/321/135/457) 
Hydrogen Bonding Restraints 59 45 
Dihedral angle restraints (phi/psi/chi1/chi2) 154 (79/66/5/4) 81(n/a) 
Average RMS deviation from experimental restraintsb 
distance restraints (Å) 
dihedral angle restraints (°) 
0.029 ± 0.00042 
0.697 ± 0.1692 
0.017 ± 0.01 
n/a 
Pairwise Cartesian RMS deviation (Å)b 
Global backbone heavy atoms 
Global all heavy atoms 
Orderedc backbone heavy atoms 
Ordered all heavy atoms   
 
1.39 ± 0.36 
2.39 ± 0.38 
0.52 ± 0.09 
2.19 ± 0.38 
 
0.41 ± 0.09 
1.08 ± 0.10 
n/a 
n/a 
Ramachandran quality parameters (%)d 
Residues in favored regions 
Residues in allowed regions 
Residues in additionally allowed regions 
Residues in disallowed regions 
 
85.5 
13.4 
0.6 
0.5 
 
64.6 
32.7 
2.1 
0.6 
Errors found in Structural Checksd 
Abnormally short interatomic distances 
Unusual backbone torsion angles (ψ/φ) 
Unsatisfied H-bond donors (buried) 
Unsatisfied H-bond acceptors (buried) 
 
1 
11 
12 
0 
 
1787 
293 
377 
30 
Average RMS deviation from current reliable structures (RMS Z-scores, null deviation = 
1)d 
Bond lengths 
Omega Angle Restraints 
Sidechain Planarity 
Improper dihedral distribution 
Inside/Outside distribution 
1.066  
1.493  
1.081 
0.870 
1.001 
0.256  
0.160 
0.057 
0.283 
0.957 
Average deviation from current reliable structures (Z-scores, null deviation = 0)d 
2nd generation packing quality 
Ramachandran plot appearance 
Chi-1/chi-2 rotamer normality 
Backbone conformation 
-1.157 
-1.311 
-1.712 
-1.962 
-2.663 
-5.108 
-4.820 
-4.348 
a PDB accession codes for PDZ2 and its human orthologue are 1GM1 and 3PDZ 
respectively.  
b Data listed for the human orthologue (Kozlov et al., 2000). 
cResidues involved in secondary structure: 12-19, 27-32, 41-47, 52-56, 64-68, 71-72, 78-86 
and 91-98 
d Values based on WHAT-CHECK (Hooft et al., 1996) output. WHAT-CHECK reports are 
available for every structure deposited in the Protein Data Bank. 
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The sequential alignment was adjusted by a structural alignment performed 
by the program WHAT-IF (Vriend, 1990). The results are shown in Figure 
2.2B. The structures were compared using backbone displacement values. 
These were calculated using structurally conserved regions (Figure 2.2B) in 
order to prevent the gross misalignment in L1 from biasing the result. These 
calculations yielded heavy-atom backbone displacement values of 1.53 Å 
for PTP-BAS, 0.94 Å for DglA, 0.93 Å for CASK and 1.33 Å for 
syntrophin. Despite very high sequence homology, the RMSD analysis 
shows that the human orthologue is the most displaced from PDZ2. This 
result was surprising as the sequence differences between the two domains 
occur mainly in loop regions. We also observed that the most significant 
structural discrepancies between PDZ2 and PTP-BAS occur between their 
respective βD strands, αB helices and L1 loops, and that these discrepancies 
are caused by different backbone dihedral angles in loops and turn regions 
(Lys 20-Gly 26, Gly 31 to Gly 41, Pro 49-Lys 50 and Thr 88-Gly 89).  
 
To probe the reasons for these differences, we completed an exhaustive 
comparison of the two structural ensembles using statistics reported by 
WHAT-CHECK (Hooft et al., 1996) and the reported data for the human 
PDZ2 ensemble. The highlights of this comparison are listed in Table 2.1. 
WHAT-CHECK reports are routinely performed for every structure 
submitted to the Protein Data Bank and are used as a diagnostic tool in the 
validation of protein structures. As Table 2.1 shows, the Ramachandran plot 
quality for PDZ2 is much higher than that of the human orthologue (86% vs. 
65% of residues in most favored regions) and PDZ2 also contains 
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significantly fewer violations of standard protein geometry than the human 
orthologue does. For example, the entire ensemble for PDZ2 contains only 1 
interatomic clash whereas 1787 clashes are reported for the human 
orthologue ensemble. Comparing RMS Z-scores shows that, without 
exception, those reported for PDZ2 are closer to the expected value of 1.0, 
than those reported for the human orthologue in PTP-BAS. Similarly, 
comparing Z scores for the two ensembles shows that the scores for PDZ2 
are consistently closer to the expected value of 0. Both of these Z-score 
comparisons demonstrate that PDZ2 conforms much better to ideal 
geometry expected from a high quality subset of X-ray structures culled 
from the PDB than the human orthologue does. In all, the PDZ2 ensemble 
should be considered a more reliable representation of this domain than that 
published for the human orthologue. 
 
We also compared PDZ2 with three X-ray structures representing the three 
interaction classes. This comparison revealed that the PDZ fold is well 
conserved despite different interaction mechanisms and considerable lack of 
sequence similarity. It also shows that the largest structural disparity occurs 
in the L1 loop region.  
 
Interactions with Protein C-termini 
The interactions of the PDZ2 domain with the C-termini of human Fas 
receptor, mouse Fas receptor and RIL protein were characterized via the 
titration of appropriate 12-mer peptides to 15N-labelled PDZ2, while 
monitoring peak differences in 15N HSQC spectra. The human Fas receptor 
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ends with the Class 1 PDZ binding sequence, -SLV* (Songyang et al., 1997) 
and acted as a positive binding control (Cuppen et al., 1997; Saras et al., 
1997a; Sato et al., 1995). The mouse Fas receptor peptide contains the 
terminal sequence -CLE*, and was not expected to bind (Cuppen et al., 
1997). RIL contains the sequence -ELV*, a modified Class 1 sequence, and 
was included with the aim of clarifying the contribution of the RIL C-
terminus to the reported PDZ2-RIL interaction (Cuppen et al., 1998). The 
titration results are shown in Figure 2.3. 
 
The PDZ2-human Fas receptor peptide complex yielded spectra indicating 
intermediate exchange. The dissociation constant was calculated to be in the 
0.2-0.5 mM range. Several residues in the binding pocket (βB and αB) were 
specifically affected by binding of the hFAS ligand, disappearing 
completely from the spectra. The mouse Fas receptor peptide interacted 
weakly and non-specifically with PDZ2, none of the affected residues being 
associated with the binding pocket. The PDZ2:RIL peptide complex was in 
fast exchange; however, the data show (Figure 2.3) very specific 
interactions with known binding site residues in PDZ2. The dissociation 
constant for the PDZ2-RIL interaction was determined to be ~1.4 mM. 
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Figure 2.3. Changes in backbone hydrogen and nitrogen chemical shifts upon titration of 
human Fas receptor (hFAS), mouse Fas receptor (mFAS), and RIL (mRIL) C-terminal 
peptides, reported as N-HN vectors. Gray bars identify peaks that were affected by an 
intermediate exchange phenomenon. 
 
Dynamics 
We performed 15N relaxation measurements to probe the dynamical 
behavior of the PDZ2 domain. We recorded the {1H}15N-NOE, 15N-T1 and 
15N-T1ρ experiments and calculated the overall tumbling rate (τc), internal 
correlation time (τe) and order parameters (S
2) using a reside-by-residue 
fitting the relaxation rates using an isotropic diffusion model (Lipari and 
Szabo, 1982a; Lipari and Szabo, 1982b) (see Figure 2.4). The relaxation 
data were fitted and analyzed using Modelfree 4.01 (Mandel et al., 1995). 
Of the 80 residues, 50 were fit using model 1, 13 with model 2 and 7 with 
model 4, as displayed in Figure 2.4. One residue, residue 101, was not fit 
well by any model, and was fit with model 1. An initial estimate of the 
global τc was optimized to 6.70 ns, a value that is typical of a compactly 
folded protein of this size. Regions associated with loops and turns show 
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increased mobility, as indicated by Rex and τe contributions. Notably, 
residues in the L1 loop are affected by both Rex and τe contributions. These 
residues also display lower {1H}15N-NOE values which are indicative of 
flexibility in the picosecond timescale. 
βA βB βC βD βE βFαA αB
 
Figure 2.4. 15N Relaxation data and results of Lipari-Szabo analysis for PDZ2 as a function 
of residue number: {1H}15N-NOE, R1, R1ρ and S
2, τe and Rex. The secondary structure of 
PDZ2 is indicated at the top. 
 
Most secondary structure elements display S2 values above the 0.89 
average. The S2 values of βA are lower than the average, indicating greater 
flexibility, perhaps explained by its location on the edge of the β-sheet. The 
βA-to-βB, βC-to-αA turn and the αB-to-βF turns also display S2 values that 
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are lower than the average. Notably, residues Leu 85 and Thr 88 display 
increased mobility with respect to neighboring residues, demonstrated by 
lower S2 values and increased τe values. These residues also display 
isolated, well defined peaks in the 15N HSQC and other spectra, ruling out 
the possibility of interference due to overlap (data not shown). These 
residues are located near the C-terminal cap of αB. The sidechain of Leu 85 
and the methyl group of Thr 88 point inward while the sidechain oxygen of 
Thr 88 faces outward. 
2.3 Discussion 
The PDZ2 ensemble of 35 structures is well defined with very good local 
geometry. We superposed PDZ2 with three X-ray structures representing the 
three interaction classes. This superposition shows that PDZ fold is highly 
conserved among all classes despite sometimes considerable sequence 
dissimilarity. To assist in quality assessment, we also superposed PDZ2 its 
human orthologue, PTP-BAS. Of the superposed PDZ domains, PTP-BAS 
was both the most sequentially similar and the most structurally dissimilar 
to PDZ2. A structural comparison of the PDZ2/PTP-BAS ensembles reveals 
several regions with significant differences in their respective ψ/φ dihedral 
angles. For instance, all β turns in PDZ2 fall into either type I’ or II classes, 
whilst in the structure of the human orthologue, several of the turns are not 
possible to classify (Hutchinson and Thornton, 1994). On all counts, 
comparisons of the two ensembles show that the PDZ2 compares better with 
data derived from current reliable X-ray structures than does the PTP-BAS, 
as reported by WHAT-CHECK (Hooft et al., 1996). General evaluations, 
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such as Ramachandran quality, give much more negative values for PTP-
BAS ensemble, and of particular concern are the high quantities of negative 
quality indicators this ensemble displays, such as interatomic clashes and 
unpaired hydrogen bond donors/acceptors. Comparing (RMS) Z-scores 
clearly show that PDZ2 is statistically a more reasonable ensemble than that 
of PTP-BAS. Including electrostatic terms in the PDZ2 refinement 
procedure contributed to a well-defined PDZ2 ensemble. These terms are 
typically implemented incorrectly in structure refinement protocols, and 
frequently resulting in poor local geometry for NMR structures. The 
modified procedure used here has been reported elsewhere (Spronk et al., 
2002). 
 
The extended L1 loop of PDZ2 folds back onto the backbone, a unique 
structural feature that PTP-BAS shares. Lower {1H}15N-NOE values and 
chemical exchange contributions to T1ρ clearly confirm L1 has increased 
flexibility with glycine hinges contributing to this flexibility, refuting data 
previously reported for PTP-BAS (Kozlov et al., 2000). It is conceivable 
that this flexibility could assist in binding target selectivity, since this effect 
has already been demonstrated for alternative L1-splicing (Erdmann et al., 
2000).  
 
The dynamic properties of PDZ2 show a normal pattern; secondary 
structures are more rigid and loop structures are more flexible. Of interest 
are the dynamic properties of Leu 85 and Thr 88. Both possess low S2 when 
compared to surrounding residues, and τe contributions on the order of 30-
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50 ps. Leu 85 is located near the C-terminal end of αB, while Thr 88 is 
located in a turn-like region just as the strand exits αB. Leu 85 participates 
in an α-helical hydrogen bonding pattern; the amide of Leu 85 participates 
in hydrogen bonding with the carbonyl of Ala 81. The sidechain oxygen of 
Thr 88 is hydrogen bonded to the amide of Leu 85, suggesting that the 
flexibility of these two residues is linked. Comparisons with other PDZ 
complexes show that Leu 85, in conjunction with Leu 25 and Ile 27, form a 
hydrophobic pocket that interacts with the terminal hydrophobic residue of 
bound C-termini. Leu 85 and Thr 88 are found in a region that is structurally 
conserved (Figure 2.2B), allowing for the possibility that the mobility of 
these two residues has a functional significance. 
 
 
Figure 2.5. Surface representation of PDZ2 with RIL peptide modeled into the binding 
pocket. 
 
Mouse PDZ2 specifically binds to peptides derived from C-termini of both 
human Fas receptor and the RIL protein with respective dissociation 
constants of 0.2-0.5 and ~1.4 mM. The complex with the human Fas 
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receptor was in the intermediate exchange and with RIL in the fast exchange 
regime. Because the amounts of human Fas and RIL peptides available for 
interaction with PDZ2 were limited by solubility, these dissociation 
constants should be viewed as upper limits, the actual binding affinities are 
most likely greater than observed. Of the three peptides, the greatest affinity 
for the human Fas receptor peptide was expected because it contains a 
known PDZ-binding Class 1 sequence, and has previously been shown to 
bind the human orthologue of PDZ2 (Sato et al., 1995; Saras et al., 1997a). 
We modeled the RIL peptide into the PDZ2 binding pocket to clarify why 
its modified Class 1 sequence (-ELV*) is able to bind to PDZ2 with specific 
interactions in the binding pocket. The chemical shift changes correlate 
strongly with modeled peptide interactions. Eight putative hydrogen bonds 
with PDZ2 and the RIL peptide (based on angle and distance constraints) 
involve the carboxyl and amide groups of the modeled peptide residues P0 
and P–2 (Figure 2.5). All of these hydrogen bonds agree with previously 
reported hydrogen bonding interactions (Doyle et al., 1996). Based on 
homology, a 180° plane flip of His 78 upon peptide binding would permit 
interaction between its N1 nitrogen and the sidechain of the P–2 residue. The 
model, being based on the free protein, does not display this interaction. The 
model also does not readily suggest the formation of hydrogen bonds to 
other sidechain atoms; the lack of these interactions could give reason to the 
comparative weakness of the observed RIL interaction. The sidechain of the 
P–2 glutamic acid points out of the binding pocket toward αB, illustrating 
why both serine and the bulkier glutamic acid sidechains are tolerated in this 
position. These results confirm previous reports of PDZ2-RIL interaction 
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and support a C-terminal contribution to this interaction (Cuppen et al., 
1998). Because the RIL C-terminus occupies the canonical binding site of 
PDZ2, we postulate that PDZ2 contains a second binding site that interacts 
with the LIM domain. The RIL-LIM domain contains a long, flexible tail of 
more than 20 residues that would provide enough conformational freedom 
to allow the LIM domain to reach such an alternate binding site. The mouse 
Fas receptor does not contain a canonical PDZ binding sequence and 
interacts only weakly and non-specifically with mouse PDZ2. Contrary to 
the human and mouse Fas receptors, the sequence for the human and mouse 
RIL C–termini are identical, suggesting a functional conservation. In 
addition, the absence of interaction between mouse PDZ2 and its Fas 
receptor suggests that the Fas receptor is an unlikely in vivo target for 
PDZ2, supporting previous results (Cuppen et al., 1997).  
 
In conclusion, we reported the structure, dynamics and binding 
characteristics of the PDZ2 domain of PTP-BL. These data represent an 
essential step in elucidating the interactions mediated by the PDZ domains 
of PTP-BL, in particular those with LIM domain-containing proteins. 
2.4 Experimental Procedures 
Sample Preparation 
The protein domain contained 8 residues of a His tag (Met + 6 His + Met) 
and 94 residues encompassing the PDZ2 domain (residues 1351 to 1444, 
accession number NP_035334) inserted into a modified pET28a plasmid 
vector (Hoffmann et al., 1997). Protein expression was induced at 37°C 
under kanamycin selection in Escherichia coli BL21(DE3) cells by addition 
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of IPTG for 4 hours. The cell pellet was resuspended in a HEPES buffer (pH 
7) in the presence of protease inhibitors, sonificated, and then centrifuged 
twice at 10000 rpm for 30 minutes to remove cell debris. The supernatant 
was passed through a Ni2+-NTA agarose column (Qiagen) and bound 
protein was first washed with 20 mM imidazole and eluted with 500 mM 
imidazole in a pH 7.9 HEPES buffer. Selected fractions were diluted and 
run through a S-sepharose fast flow cation exchange column (Amersham 
Pharmacia), from which the protein was eluted using a 0-1M NaCl gradient 
in a pH 7 HEPES buffer. Fractions containing the protein were then 
dialyzed against water, lyophilized and stored at -75°C. Uniformly 15N/13C-
labelled PDZ2 samples were prepared using 15N NH4Cl and 
13C glucose as 
sole nitrogen and carbon sources. NMR samples contained ~1 mM 
dissolved protein in a buffer of 50 mM KH2PO4/K2HPO4 and 50 mM KCl, 
pH 6.8, H2O/D2O (95%/5%), using Pefabloc and trace NaN3 as preservative. 
 
Peptide Interactions 
The peptides, ordered from Ansynth Service BV (Roosendaal), contained an 
N-terminal biotin group and a C-terminal carboxyl group. The peptide 
sequences corresponded to the final twelve C-terminal residues of three 
proteins, NSNFRNEIQSLV* (human Fas receptor, accession number 
P25445), DTGNENEGQCLE* (mouse Fas receptor, accession number 
NP_032013) and VAVYPNAKVELV* (RIL accession numbers: mouse 
NP_062290 and human P50479). The peptides were titrated up to 3.5 mM 
into individual 1 mM 15N-labelled protein samples. The differences in 
backbone HN and N chemical shifts were monitored via 15N-HSQC spectra, 
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recorded on the equilibrated samples at 600 MHz and 25°C. The (initial – 
final) HN and N frequencies (Hz) and relative concentrations were fit using 
a least squares procedure to determine dissociation constants for the 
peptides. For the human Fas receptor peptide, the change in peak intensity 
vs. the relative concentration was used due to the intermediate exchange 
phenomena. 
 
NMR Spectroscopy 
NMR experiments were collected at 25°C on a double-labeled 13C/15N 
sample with the exception of the 15N NOESY-HSQC, which was recorded 
on a single-labeled 15N sample. The NMR experiments were carried out on 
Varian 500, Varian 600, Bruker 600 and Varian 750 spectrometers. The data 
were processed and analyzed using the NMRPipe suite (Delaglio et al., 
1995) and XEASY (Bartels et al., 1995). The complete resonance 
assignment was completed using 3D HNCA, HNCO, C(CO)NH, HNCACB, 
HNHA, HNHB, CBCA(CO)NH, HBHA(CBCACO)NH, H(C)CH-TOCSY 
and (H)CCH-TOCSY experiments. The NOE assignments were completed 
on an aliphatic 3D 13C-NOESY-HSQC and an aromatic 3D 13C-NOESY-
TROSY recorded on a Varian 750, and also a 3D 15N-NOESY-HSQC 
recorded on a Bruker 600, all with mixing times of 100 ms. 3J-coupling 
values were derived from 3D HNHA, HN(CO)CO, HNCACO[N] and 
LRCC experiments (obtaining the 3J(HNHα), 3J(Ci-1Ci), 3J(HαiNi+1) and 
3J(CC) coupling constants). The T1, T1ρ and {
1H}15N-NOE experiments 
were recorded at 25°C on a Varian 600 MHz spectrometer. The relaxation 
delays for duplicate T1 experiments were T = 0.0160, 0.3840, 0.5120, 
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0.6400, 1.0240 s and T = 0.0160, 0.2560, 0.5120, 0.7680, 1.0240 s. The 
relaxation delays for the T1ρ experiment were T = 0.0160, 0.0320, 0.0480, 
0.0800, 0.0960, 0.1120, 0.1280 s. 
 
Structure Refinement 
The NOE peak volumes were converted into distance ranges by 
normalization against peak volumes that were calibrated to known distances, 
and then overestimated twofold. Distance restraint ranges defined with 
lower limits of 0 Å and upper limits of 2.8, 3.5, 5.0 or 7.0 Å. 154 angle 
restraints were obtained from 3J-couplings. 59 hydrogen bond restraints 
were derived from CSI determined secondary structures and confirmed by 
characteristic NOE patterns. Hydrogen bonds for the HN-O and the N-O 
distances were restrained from 1.2-2.2Å and 2.2-3.2 Å respectively. An 
initial set of 200 NMR structures was calculated using a Cartesian-space 
simulated annealing protocol in X-PLOR version 3.851 (Brunger, 1996). To 
improve local geometry and electrostatics, 70 lowest energy structures were 
then refined in water using a restrained molecular dynamics protocol under 
a CHARMM22 force field (Spronk et al., 2002). This resulted in a set of 43 
structures with no distance restraint violations > 0.5Å and no dihedral angle 
violations > 5°. Of these, the 35 lowest energy structures were selected to 
form the final ensemble. Structures were analyzed using the programs 
PROCHECK-NMR (Laskowski et al., 1996) and WHAT-IF (Vriend, 1990). 
The modeling of the RIL C-terminal peptide was accomplished using the 
syntrophin/nNOS interaction (PDB entry 1QAV) as a template using 
WHAT-IF (Vriend, 1990). The PDZ domains of PDZ2 and syntrophin were 
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first superposed and then the bound interaction partner was mutated to RIL 
sequence. Finally, minor debumping was performed to remove steric 
clashes. The figures were prepared using MOLMOL (Koradi et al., 1996). 
The coordinates of the structures were deposited in the Protein Data Bank 
under PDB accession number 1GM1 and the chemical shifts and 15N 
relaxation data are deposited in the BioMagResBank under BMRB 
accession number 5131. 
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Chapter 3 
A closed binding pocket and global destabilization modify the 
binding properties of an alternatively spliced form of the second 
PDZ domain of PTP-BL.1 
Summary 
PTP-BL is a large phosphatase that is implicated in cellular 
processes as diverse as cytokinesis, actin-cytoskeletal rearrangement 
and apoptosis. Five PDZ domains mediate its cellular role by 
binding to the C-termini of target proteins, forming multi-protein 
complexes. The second PDZ domain (PDZ2) binds to the C-termini 
of the tumor suppressor protein APC and the LIM domain-
containing protein RIL; however, in one splice variant, PDZ2as, a 
five residue insertion abrogates this binding. Using NMR we 
determined that the insert causes distinct structural and dynamical 
changes in the alternatively spliced PDZ2: enlarging the L1 loop 
between βB and βC, both lengthening and changing the orientation 
of the αB helix, giving the base of the binding pocket less flexibility 
to accommodate ligands and destabilizing the entire domain. These 
                                                 
1
 Walma T, Aelen J, Nabuurs SB, Oostendorp M, van den Berk L, Hendriks W, and 
Vuister GW. (2004). Structure 12, 11-20. 
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changes render the binding pocket incapable of binding C-termini, 
possibly having implications in the functional role of PTP-BL. 
3.1 Introduction 
PTP-BL is a large cytosolic protein which contains an N-terminal KIND 
domain, a FERM domain, common to membrane-cytoskeleton linker 
proteins, five PDZ domains (labeled PDZ1 to PDZ5), and a C-terminal 
phosphatase domain. The FERM domain is responsible for localization to 
the membrane side of epithelial cells (Cuppen et al., 1999b) and can be 
cosedimented with filamentous actin (Herrmann et al., 2003). Studies have 
shown that overexpression of catalytically inactive PTP-BL in HeLa cells 
led to defects in cytokinesis and resulted in multinucleate cells (Herrmann et 
al., 2003), but the underlying substrates have not yet been identified. To 
date, PTP-BL has been found capable of dephosphorylating the proteins RIL 
(Cuppen et al., 1998), β-catenin (Erdmann et al., 2000), Src and ephrinB 
(Palmer et al., 2002). However, most attempts at elucidating the biological 
role of PTP-BL have been focused on identifying binding partners for its 
five PDZ domains, protein modules that bind to C-termini and orchestrate 
the formation of multi-protein complexes (van Ham and Hendriks, 2003). 
 
The PDZ domains of PTP-BL have been shown to interact with several 
proteins: PDZ1 interacts with BP75 (Cuppen et al., 1999a), both PDZ2 and 
PDZ4 with TRIP-6 and RIL (Cuppen et al., 2000; Cuppen et al., 1998), 
PDZ2 interacts with APC (Erdmann et al., 2000) and RA-GEF-2 (Kozlov et 
al., 2002), PDZ3 binds to PRK2 (Gross et al., 2001), and PDZ4 binds to 
ephrinB1 (Palmer et al., 2002) and CRIP2 (van Ham et al., 2003). It is clear 
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from these many studies that the PDZ domains of PTP-BL can interact with 
a multitude of proteins; however, the functional implications of these 
interactions have yet to be linked in a cohesive scheme. A reported binding 
of the PDZ2 domain of PTP-BAS (the human orthologue of PTP-BL, also 
known as PTPL1, FAP-1, PTP1e and PTPN13) to the human Fas receptor 
led to a proposed role in apoptosis regulation (Sato et al., 1995) but this 
finding was subsequently challenged by other studies (Cuppen et al., 1997; 
Walma et al., 2002; Chapter 2). The interactions with RIL, TRIP-6, and 
CRIP2 all reveal actin-cytoskeleton-related staining patterns and the 
interactions with PARG, a Rho-specific GTPase-activating protein (Saras et 
al., 1997), and PRK2, a Rho effector kinase (Gross et al., 2001), support a 
role for PTP-BL in microfilament dynamics. In addition, PTP-BL has been 
linked to actin-cytoskeletal rearrangements induced by ephrinB ligand 
signaling (Palmer et al., 2002). Although its precise function is unknown, 
mutations in APC have been linked to human familial and sporadic colon 
cancer (Erdmann et al., 2000). Finally, overexpression studies in HeLa cells 
suggest a role for PTP-BL in the regulation of cytokinesis (Herrmann et al., 
2003).  
 
The web of intracellular interactions involving PTP-BL is further 
complicated by its four isoforms. These isoforms result from alternative 
splicing and have specific expression patterns (Maekawa et al., 1999; Saras 
et al., 1994; Banville et al., 1994; Erdmann et al., 2000; Herrmann et al., 
2003). The four isoforms result from splice differences in three different 
regions. The first alternatively spliced region corresponds to the central part 
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of the N-terminal domain between the KIND and FERM domain. This 
region was shown to be responsible for midbody localization during 
cytokinesis (Herrmann et al., 2003). The second region encodes the protein 
region between the FERM domain and PDZ1. The third region involves 
residues within the PDZ2 domain. Due to alternative splice donor sites, 
either a short PDZ2 domain of 93 residues or an alternatively spliced 
isoform containing 98 residues is produced (Erdmann et al., 2000). The 
difference of five residues between the shorter PDZ2 domain and its longer 
splice variant in isoform 4 (PDZ2as) has been reported to effectively 
abrogate binding to the C-terminus of APC (Erdmann et al., 2000). Isoform 
4 was also shown to be involved in the regulation of cytokinesis and 
cosedimented with microtubules (Herrmann et al., 2003). 
 
The distribution and ratio of the two PDZ2 splice forms show that PDZ2as-
containing mRNA transcripts are co-expressed with PDZ2-containing 
transcripts in most tissue and cell types (Sato et al., 1995; Erdmann et al., 
2000). The deduced tissue expression pattern of PDZ2as ranges from 
virtually absent (kidney) to ~20 % of PTP-BL mRNAs (lung). Thus, the 
ratio is cell type specific. Since both the protein stability and sub-cellular 
distribution could differ for the two PDZ2 splice variants, it may well be 
that local ratios at specific sub-cellular sites differ from the above estimates. 
 
The interactions of PDZ domains with C-termini are generally grouped into 
four classes. Class 1 interactions involve -S/TxΦ* sequences (where Φ is a 
hydrophobic amino acid and * is the terminal carboxyl tail), Class 2 
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involves -ΦxΦ* C-termini, Class 3, -E/DxΦ* and Class 4, -VxD/E* 
sequences (Vaccaro and Dente, 2002). It is well documented that PDZ 
domains are promiscuous, able to bind C-termini across classes. For 
example, the Erbin PDZ domain can bind both Class 1 and 2 C-termini 
(Birrane et al., 2003), while PDZ2 from PTP-BL is able to bind both class 1 
and III C-termini (Walma et al., 2002; Chapter 2). It remains to be 
determined whether this adaptability of PDZ domains is related to their 
function as protein adaptors.  
 
PDZ domains are globular domains containing two α helices and six β 
strands. The binding pocket is located between the αB helix and βB strand. 
C-terminal ligands are bound by several conserved interactions (Vaccaro 
and Dente, 2002), such as specific hydrogen bonding to the βB strand, 
insertion of the P0 (ultimate C-terminal) residue into a hydrophobic pocket, 
and various interactions involving the P-2 (antepenultimate) residue, 
depending on the interaction class. Other residues of ligands may also 
contribute, and residues up to P-7, have been shown to interact with PDZ 
domains (Birrane et al., 2003). Exceptions to the general structural motif for 
PDZ domain-mediated interactions are known to exist. For example, PDZ7 
from GRIP contains a closed, canonical binding pocket which is thought to 
be unable to classically bind peptides and instead interacts with the C-
terminus of GRASP-1 via a hydrophobic patch on its βD-βE-αB face (Feng 
et al., 2002). 
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The structure of the short PDZ2 domain from PTP-BL was previously 
solved by us (Walma et al., 2002; Chapter 2). Here, we report the structure 
of the alternatively spliced PDZ2 domain from PTP-BL (PDZ2as), 
corresponding to isoform 4. This insert strikingly abrogates the interaction 
with class 1 and 3 ligands derived from the tumor suppressor protein APC 
and the LIM domain-containing protein RIL. Our results show that 
pronounced structural and dynamical changes render PDZ2as incapable of 
binding C-termini. 
3.2 Results 
Using high resolution NMR, we determined an ensemble of 30 structures of 
the alternatively spliced PDZ2 domain of mouse PTP-BL (Figure 3.1A). 
PDZ2as possesses a well-structured PDZ fold. The pairwise backbone RMS 
deviation for the ordered regions is 0.66 ± 0.11 Ǻ (Table 3.1). Figure 3.1C 
shows a structural superposition of PDZ2 (Walma et al., 2002) with 
PDZ2as. Both domains possess similar β-sheet and α-helical elements. Four 
of the inserted residues extend the L1 loop, while the initial valine 
structurally replaces a glycine in PDZ2, becoming the last residue in the βB 
strand (vide infra). Unlike PDZ2, the L1 loop extends unrestricted into 
space. In addition, the αB helix of PDZ2as is orientated differently. In 
PDZ2, βB and αB are virtually parallel, but in PDZ2as, the orientation of the 
αB helix angle has changed by ~30° (Figure 3.1D), remodeling the binding 
pocket (vide infra).  
 
Figure 3.1E shows the sequence alignment of PDZ2as with its own shorter 
PDZ2 variant, as well as with several representative PDZ domains. The 
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secondary structural elements of these domains are well conserved. The 
alternate binding preference of the CASK PDZ domain for class 2 peptides 
(Vaccaro and Dente, 2002) is reflected by structural differences in the αB 
helices. The alignment also shows that the structure of PDZ7(GRIP) is the 
most divergent structure from PDZ2as, with wide regions of the two 
domains being dissimilar. These differences also correlate with its altered 
binding properties. 
Table 3.1. Structural statistics for the alternatively spliced PDZ2 domain of PTP-BL 
(PDZ2as). 
Structural Statistics PDZ2as 
Restraint Information 
 Distance Restraints (intra/seq/med/long) 
 
1354 (554/311/128/361)  
 Hydrogen Bonding/dihedral (phi)/RDC 29/76/66 
Average RMS deviation from experimental restraints 
 distance restraints (Å) 
 dihedral angle restraints (°) 
 residual dipolar couplings (Hz) 
0.022 ± 0.002 
0.262 ± 0.099 
0.505 ± 0.055 
Pairwise Cartesian RMS deviation (Å) 
 Global backbone/all heavy atoms 
 Ordereda backbone/all heavy atoms 
 
2.58 ± 0.63 3.27 ± 0.55 
0.66 ± 0.11 1.45 ± 0.20 
Ramachandran quality parameters (%)b 
 Residues in favored and allowed regions 
 Residues in disallowed regions 
 
78.1/17.3 
2.1 
Average RMS deviation from current reliable structures (RMS Z-scores, null 
deviation = 1)b 
 Bond lengths 
 Bond angles 
 Omega Angle Restraints 
 Side chain Planarity 
 Improper dihedral distribution 
 Inside/Outside distribution 
0.90 
0.87 
0.77  
0.78 
0.85 
1.04 
Average deviation from current reliable structures (Z-scores, null deviation = 0)b 
 2nd generation packing quality 
 Ramachandran plot appearance 
 Chi-1/chi-2 rotamer normality 
 Backbone conformation 
-2.02 
-3.27 
-1.11 
-4.58 
a Residues involved in secondary structure: 13-19, 27-31, 47-53, 58-61, 68-73, 76-77, 83-93 
and 96-103. 
b Values based on WHAT-CHECK reports, which are available for every structure 
deposited in the Protein Data Bank. 
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Figure 3.1. Structural ensemble and sequence alignment of PDZ2as. 
(A) Structural ensemble of PDZ2as (stereo-diagram). 
(B) Protection of amides from H/D exchange. Amides are depicted as spheres; large black 
spheres indicate amides with high protection factors (>50), large gray spheres, those with 
intermediate protection factors (10-50), and small gray spheres represent amide with low 
protection factors (<10). Very small spheres indicate amides with complete solvent 
exchange within the experimental dead time of 20 minutes.  
(C and D) Structural superposition of PDZ2as (lighter grey, longer loop) with PDZ2 (darker 
grey, shorter loop). The orientation of the αB helices differ by ~30° (shown as cylinders) 
while that of the βB strands remain the same (shown as arrows).  
(E) PDZ2as (PDB code 1ozi) sequentially aligned with GRIP (1m5z), CASK (1kwa), PSD-
95 (1bfe) and DglA (1pdr). The alignments were performed on each domain with a 
maximal displacement of 7 Å for each pair of Cα atoms and a global RMS limit of 4 Å. 
Protein regions that are structurally similar to PDZ2as are indicated by underlining. The 
five residue insertion is boxed in gray. Numbering schemes are given at the top for PDZ2as 
(upper-most) and, for reference, PDZ2 (lower-most).  
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To investigate the precise differences in the size and shape of the binding 
pockets of PDZ2 and PDZ2as, we compared their sizes and volumes using 
the program CASTp (Liang et al., 1998). CASTp probes pockets and 
cavities in protein structures and characterizes these using solvent accessible 
areas and volumes. We analyzed the binding pockets of PDZ2, PDZ2as and 
PDZ7(GRIP). To obtain an insight into the inherent variation of PDZ 
domains, we compared these results to the averages obtained from 5 PDZ 
crystal structures. The results of this analysis are listed in Table 3.2. The 
mouth of the binding pocket in PDZ2 has an area of 105 ± 46 Å2 and a 
volume of 55 ± 40 Å3. These values decrease significantly to 36 ± 20 Å2 and 
13 ± 14 Å3 in PDZ2as. The pocket mouth area and volume of the X-ray 
structures are comparable to those of PDZ2, both in magnitude and 
variability. In contrast, GRIP, displays values more comparable to those of 
PDZ2as. These results correlate with the binding pocket widths between the 
βB strand and the αB helix. The PDZ domains with smaller binding pockets 
are narrower at their base, averaging below 6 Å, while those with larger 
pockets are wider, averaging above than 6.5 Å. Thus, like the GRIP domain, 
PDZ2as has a constricted binding pocket, with both a smaller mouth and 
much less volume to accommodate ligands.  
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Table 3.2. Solvent accessible mouth area, pocket volume and surface area of the wall atoms 
of the binding pocket 
PDZ 
Domain 
Protein Mouth 
Area (Å2) 
Pocket 
Volume (Å3) 
Area of Wall 
Atoms of Binding 
Pocket (Å2) 
Width of Base 
of Binding 
Pocket (Å) 
PDZ2a  PTP-BL 105 ± 46 55 ± 40 24 ± 20 6.5 ± 1.1 
PDZ2asa PTP-BL 36 ± 20 13 ± 14 5 ± 6 5.3 ± 1.2 
PDZb  X-ray 125 ± 36 89 ± 16 36 ± 5 7.5 ± 1.4 
PDZ7a GRIP 40 ± 19 12 ± 10 6 ± 5 5.6 ± 0.6 
Areas and volumes calculated using a probe size of 1.4 Å diameter, as calculated by 
CASTp (Liang et al., 1998).The binding pocket widths are calculated from the Cα-Cα 
distance between residues that structurally align with Thr 30 and His 83 in PDZ2as.  
Error bars are 1σ. 
a The values represent the average of values obtained for the 11 conformers with lowest 
pairwise RMS deviation. 
b The values represent the average obtained for 5 uncomplexed PDZ domain structures 
solved by X-ray diffraction, taken from PDB accession codes 1kwa, 1g9o, 1gq4, 1gq5, and 
1n99. 
 
To further understand the effects of the splice insert on the structure of the 
PDZ2as domain, we determined its amide exchange characteristics. The 
exchange rate is slow in regions that are protected from the solvent, such as 
the protein core, and fast in regions that are exposed. The data can also be 
interpreted to yield information about the overall stability (Huyghues-
Despointes et al., 1999). The results are displayed in Figure 3.1B. The core 
of the PDZ2as domain is formed by several highly protected residues in the 
βA, βC, βD and βF strands. These residues correlate with cross-strand 
hydrogen bonding interactions. In contrast, amides in the loops, termini and 
binding pocket are almost freely exchangeable, most exchanging faster than 
the 20 minute experimental dead time. Noticeably, amides in the binding 
pocket have low or unmeasurable protection factors, indicating full solvent 
accessibility. 
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Because the low levels of amide protection show that this domain is very 
flexible, we decided to investigate in detail how the mobility of this domain 
contributes to its altered binding characteristics. We determined the 
{1H}15N-NOE, 15N-R1 and 15N-R1ρ relaxation rates (Figure 3.2) for the 
PDZ2as domain and compared these to the results obtained for the PDZ2 
domain. We calculated the order parameters (S2), internal correlation times 
(τe) and chemical exchange contributions (Rex) for each residue. The global 
tumbling rate τc of 6.12 ns is a typical value for a protein of this size. Most 
of the secondary structural elements for PDZ2as display S2 values above the 
0.82 average. Loop L1 is much more flexible than the rest of the protein, 
with low {1H}15N-NOE values that translate into low S2 values and 
moderate τe contributions.  
 
In addition to the L1 loop, several other residues show significant flexibility. 
Leu 25 is located in the ‘GLGF loop’ preceding the βB strand. The 
flexibility of the final residue Val 106 indicates the end of the domain. The 
flexibility of Arg 91 and Gly 94 appear to be linked (Walma et al., 2002; 
Chapter 2). This type of concerted flexibility, also observed in the shorter 
PDZ2 domain, involved the preceding residues of Leu 90 and Thr 93. The 
conformation of this region differs in the two ensembles; in PDZ2as these 
residues favor a 310 helical conformation whilst in PDZ2 they form a turn-
like structure. These conformational differences led to altered hydrogen 
bonding patterns. For instance, in PDZ2as, the side chain oxygen of Thr 93 
hydrogen bonds to both the carboxyl of Leu 90 and the amide of Gly 94 
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while in PDZ2, this side chain of Thr 93 hydrogen bonds only to the 
carboxyl of Leu 90. 
 
We compared the PDZ2 and PDZ2as domains using the program QUEEN 
(Nabuurs et al., 2003) (Quantitative evaluation of experimental NMR 
restraints). QUEEN allows users to quantify and rank NOEs by how much 
structural information each contributes to a structure. Table 3.3 lists the 25 
most important NOEs in PDZ2. It is interesting that Val 29 is involved in 
5/25 of these structurally important NOEs. The single most important NOE 
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Figure 3.2. Dynamics of PDZ2as. 
The experimental relaxation data ({1H}15N-NOE, R1 and R1ρ) were fit to yield values 
for S2, τe and Rex for PDZ2as (black bars) and PDZ2 (Walma et al., 2002; Chapter 2) 
(gray line) as a function of residue number. Numbering refers to PDZ2as (upper) and 
PDZ2 (lower). The secondary structure of PDZ2as is indicated at the top, helices 
(triangles) and strands (bars). The five residue insertion is shaded grey. 
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between Val 29 and Leu 90 anchors the βB strand to the αB helix across the 
binding pocket. This NOE is clearly present in the PDZ2 spectra, and it is 
just as clearly absent in PDZ2as spectra. In the PDZ2as ensemble this 
distance is 0.7 Å longer than in PDZ2, placing it beyond typical NOESY 
detection limits (Wüthrich, 1986). The NOE between the side chain methyl 
groups of Val 16 and Gly 62 is also not observed in the PDZ2as spectra. Gly 
62 is located in the irregular αA-to-βD turn region, which differs structurally 
in the two ensembles. In PDZ2, several hydrophobic contacts between Val 
33 and the βE-to-αB turn structure the L1 loop. However, in PDZ2as, these 
contacts involve Val 31. The insertion additionally disrupts other NOEs that 
constrain the loop in PDZ2. Other than the aforementioned exceptions, we 
were able to locate the balance of the NOEs listed in Table 3.3 in the 
respective NOESY spectra. 
 
We further validated the structural differences between PDZ2 and PDZ2as 
using residual dipolar couplings. We measured 1DHN RDCs for both 
domains and calculated Q-factors. Q-factors represent the agreement 
between structurally predicted and experimentally measured dipolar 
couplings, lower values indicate better agreement (Cornilescu et al., 1998). 
Even before refinement, the RDCs for the PDZ2as domain showed a very 
good agreement with its structure, with a Q-factor of 0.23. When these 
RDCs are used in the refinement, this Q-factor improves to 0.11. The PDZ2 
domain also agrees well with own RDCs with a Q-factor of 0.36. However, 
these dipolar coupling datasets are not interchangeable. For instance, when 
the 1DNH RDC dataset from PDZ2 is superposed onto PDZ2as structure, the 
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Q-factor rises to 0.52, reflecting an essential structural rearrangement of the 
PDZ2as structure with respect to PDZ2. These results are illustrated in 
Figure 3.3C. The predicted and measured RDCs of PDZ2as show good 
agreement whereas the dipolar couplings of the PDZ2 domain superposed 
on the PDZ2as structure are skewed, with several outliers greater than 10 
Hz. 
Table 3.3. Comparison of distances corresponding to the 25 most structurally important 
NOEs in PDZ2 and PDZ2as. 
Rank Residue 1 Residue 2 PDZ2 (Å) PDZ2as (Å) Difference (Å) 
1 Val 29 (H
γ1
)3/(H
γ2
)3 Leu 90 H
N
 6.8 ± 0.7 7.5 ± 0.7 + 0.7 
2 Leu 25 (Hδ1)3/(H
δ2)3 Val 97 H
β 4.1 ± 1.2 3.8 ± 0.9  - 0.3 
3 Val 73 (Hγ1)3/(H
γ2)3 Ala 86 H
α 5.4 ± 0.6 5.6 ± 1.0 + 0.2 
4 Val 29 (Hγ1)3/(H
γ2)3 Val 49 H
α 4.7 ± 0.7 4.5 ± 0.7 - 0.2 
5 Val 16 (Hγ1)3/(H
γ2)3 Gly 62 H
N 6.9 ± 0.6  8.2 ± 1.2 + 1.3 
6 Ile 64 (Hδ1)3 Leu 101 (H
δ1)3/(H
δ2)3 5.1 ± 1.3 4.0 ± 0.8  - 1.1 
7 Val 29 (Hγ1)3/(H
γ2)3 Ala 86 H
β2/ Hβ3 5.1 ± 1.8 4.5 ± 0.8 - 0.6 
8 Ile 47 Hβ Leu 78 (Hδ1)3/(H
δ2)3 4.7 ± 2.3 4.9 ± 2.0 + 0.2 
9 Val 29 (Hγ1)3/(H
γ2)3 Val 87 H
α 5.0 ± 0.8 5.3 ± 0.7 + 0.3 
10 Leu 101 Hδ1/ Hδ2 Lys 103 HN 5.8 ± 0.9 7.6 ± 0.9 + 1.8 
11 Ile 47 (Hγ2)3 Val 70 H
β 3.5 ± 0.8  4.0 ± 1.3 + 0.5 
12 Lys 20 Hε2/Hε3 Val 97 (Hγ2)3/(H
γ3)3 5.2 ± 2.7 5.1 ± 1.3 -0.1 
13 Arg 69 HN Val 106 HN 3.6 ± 2.2 8.0 ± 2.0 + 4.4 
14 Arg 69 HN Glu 102 Hβ2/Hβ3 4.0 ± 0.8 4.7 ± 0.8 + 0.7 
15 Val 70 Hα Leu 101 Hα 2.9 ± 1.0  2.4 ± 0.4 - 0.5 
16 Pro 10 Hβ2/ Hβ3 Gln 105 Hα 3.3 ± 2.3 6.0 ± 2.2 +2.7 
17 Val 97 (Hγ1)3/(H
γ2)3 Leu 99 H
N 5.6 ± 0.5 5.5 ± 1.2 - 0.1 
18 Val 38 HN Thr 82 Hα 2.5 ± 0.6 - + Large 
19 Val 16 (Hγ1)3/(H
γ2)3 Leu 99 H
γ 4.4 ± 0.9 6.9 ± 0.6 + 2.5 
20 Asn 39 HN Thr 82 Hα 3.9 ± 2.1 - + Large 
21 Val 42 (Hγ1)3/(H
γ2)3 Ile 47 H
α 6.4 ± 1.9 10.9 ± 4.2 + 4.5 
22 Val 29 (Hγ1)3/(H
γ2)3 Val 87 H
N 6.1 ± 1.3 5.3 ± 0.8 - 0.8 
23 Ile 47 (Hγ2)3 Val 87 H
N 6.3 ± 0.2 6.1 ± 0.5 -0.2 
24 Val 16 HN Gly 99 HN 3.3 ± 0.5 3.2 ± 0.5 -0.1 
25 Ile 47 Hβ Val 70 Hβ 2.8 ± 1.5 2.5 ± 1.2 -0.3 
Structurally important NOEs were determined using QUEEN (Nabuurs et al., 2003). NOEs 
involving Valine 29 are shown in bold and NOEs not observed in the PDZ2as structure are 
italicized. Distances involving methyl groups refer to a 1/r-6 averaging, resulting from non-
stereospecific assignments. 
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Figure 3.3. Comparison of ligand binding to and structures of PDZ2as and PDZ2. 
(A and B) Excerpts of 15N-HSQC spectra from PDZ2as (A) and PDZ2 (B). Superposed are 
the spectra of each domain alone (black) and in complex with the APC ligand (gray). The 
C-terminus of APC interacts minimally with PDZ2as (A) but strongly with PDZ2 (B).  
(C) Measured versus predicted 1DHN RDCs. Solid data points show the 
1DHN RDCs of 
PDZ2as fitted to its own ensemble. Open data points show the 1DHN RDCs of PDZ2 fitted 
onto the PDZ2as ensemble (Q factor 0.52). 
 
We tested the binding properties of PDZ2as using two peptides to represent 
the class 1 and 3 C-termini that are known to interact with PDZ2. One 
peptide was derived from APC (Erdmann et al., 2000) and the second was 
derived from RIL (Walma et al., 2002; Chapter 2). We were especially 
interested in the binding properties of APC because it was previously 
reported that the tight binding of APC with PDZ2 was completely abolished 
with PDZ2as (Erdmann et al., 2000). Figure 3.3A-B clearly demonstrates 
the difference in binding affinities of these two domains. For PDZ2as, the 
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amide of Gly 26, located in the carboxylate binding loop, is marginally 
affected by the presence of the ligand, while it shifts more than 0.5 ppm in 
case of the PDZ2 domain. These two ligands bind to PDZ2 with varying 
affinities; the Kd of APC was previously reported to be as strong as 8.1 nM 
based on SPR measurements (Erdmann et al., 2000), whereas our own NMR 
data show this interaction to be in the intermediate exchange regime with a 
Kd of 200 µM (Figure 3.3B), see experimental procedures for details. The 
interaction of PDZ2 with the RIL peptide was determined by NMR to be in 
the fast exchange regime (often associated with weak interactions) with a Kd 
of 1.4 mM (Walma et al., 2002; Chapter 2). 
 
Both the APC and RIL C-terminal ligands bind very poorly to PDZ2as with 
interactions in the fast exchange regime. In fact, only three residues show 
signs of interaction with the APC ligand, with minor chemical shift changes. 
However, it is interesting to note that two of these residues are located in the 
binding pocket of PDZ2as (i.e. Gly 26 and Ile 27). Due to the weakness of 
the interaction, a dissociation constant for the PDZ2as-APC ligand could not 
be determined. The effects of the interaction of the RIL ligand with PDZ2as 
were also small, but clearly present. Approximately half of the residues 
showed perceptible interactions; in particular Gly 26 shifted more than 60 
Hz (0.1ppm). Based on these data, we determined the Kd of the RIL ligand 
to be ~19 mM.  
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3.3 Discussion 
Structure and Flexibility 
The PDZ2as structural ensemble is well defined with very good local 
geometry, as indicated by the low Q-factor of 0.11 for the 1DNH RDCs. 
Some regions of the domain are unique to PDZ2as, such as the long L1 loop 
connecting the βB and βC strands. The flexibility of the L1 loop is clearly 
demonstrated by the relaxation data, with order parameters ranging from 0.6 
to 0.7 and also by low amide protection factors. Unexpectedly, the inserted 
residues Leu 32, Phe 33 and Asp 34 have S2 values of ~0.9, which are 
typical of secondary structural elements, while the rest of the L1 loop is 
much more flexible when compared to PDZ2. 
 
The pattern of amide protection factors indicates that the core of the protein 
is located on the side of the PDZ domain opposite to the binding pocket. 
The amides of loops and turns were freely exchangeable within the 
experimental dead time. The binding pocket is also very unprotected, even 
the αB helix, which is surprising because α helices typically have high 
protection factors due to their regular hydrogen bonding patterns. 
 
The conformational stability, ∆GHX , calculated from the three amides with 
the highest protection factors reveals a low thermodynamic stability of 2.8 
kcal/mol for PDZ2as (Huyghues-Despointes et al., 1999). Indeed, the amide 
exchange rates could only be determined at low pH and temperature, 
because the exchange rate is both acid and base catalyzed in these 
conditions, and reaches a minimum rate (Englander and Mayne, 1992; Bai 
72  Chapter 3 
et al., 1993). This value is much lower than the 4.8 ± 0.4 kcal/mol 
stabilization which was reported for the short human orthologue of PDZ2 
(Ekiel et al., 1998), and is also lower than the 4.8 kcal/mol stability reported 
for the second PDZ domains of syntenin (Kang et al., 2003). The relatively 
fast exchange of even the most protected amides indicates that they are 
transiently solvent-exposed (Dempsey, 2001), indicating a high level of 
intrinsic flexibility. There is a noticeable difference in mobility between the 
ordered and loop regions in PDZ2as, while in PDZ2 this difference is 
negligible (Figure 3.2). Thus, in PDZ2as, the insertion appears to cause a 
global destabilization which affects the loop and turn regions even more 
than the ordered regions. This destabilization is also suggested by the 
substantially decreased lifetime of the domain in the NMR tube, reduced 
from more 2 years for PDZ2 to a period of weeks for PDZ2as. 
 
Other residues in or near the binding pocket also show significant 
flexibility. The linked flexibility of Arg 91 and Gly 94 appears to be 
inherent since this type of linkage was also observed in PDZ2 between 
residues Leu 90 and Thr 93. We explained this linkage as resulting from a 
hydrogen bond between the side-chain oxygen of Thr 93 and the HN of Leu 
90 (Walma et al., 2002; Chapter 2). In both PDZ2 and PDZ2as, this linked 
flexibility retains its position relative to the end of the C-terminal helix cap 
of αB, since this helix is longer in PDZ2as. We hypothesize that this linked 
flexibility is involved structurally in C-terminal capping; however, we have 
not excluded the possibility that the mobility of these residues has a 
functional role.  
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Interactions 
The APC and RIL ligands bind to the PDZ2 domain of PTP-BL with 
dissociation constants of 190 µM and 1.4 mM (Walma et al., 2002; Chapter 
2; Chapter 4). The dissociation constants for the interactions of these two 
peptides with PDZ2as are reduced to levels that are not physiologically 
relevant, i.e. undeterminable and ~19 mM for APC and RIL respectively, in 
accordance with prior biochemical and SPR data. 
 
Dissociation constants for other PDZ-ligand complexes serve as useful 
comparisons. The Kd of a class 1 peptide interaction with the human 
orthologue of PDZ2, confirmed by Gdm-HCl denaturation and fluorescence 
emission spectroscopy, was reported to be in the 30 µM range (Ekiel et al., 
1998). Studies on the PDZ domains of syntenin using ITC and fluorescence 
have yielded Kd values in the low to mid-µM range (Kang et al., 2003). 
These dissociation constants are consistent with the function of PDZ 
domains as protein adaptors: high enough to attract binding partners yet still 
weak enough to allow the binding partner to disengage after other 
biologically important interactions have taken place. 
 
It is interesting to note that the C-terminal ligands still preferentially interact 
with PDZ2as in the binding pocket, as evinced by chemical shift changes for 
a key binding site residue Gly 26, (Figure 3.3A-B); however, it appears that 
the increased sterical hindrance prevents efficient binding. Furthermore, the 
class 3 RIL sequence retains more interaction ability with PDZ2as than the 
class 1 APC sequence. A reason for this could be that the longer P-2 
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glutamic acid side-chain of the RIL ligand is more able to maintain its 
interaction with the His 83 side-chain, thus conserving more of the 
interactions that are necessary for binding (Novak et al., 2002). 
 
To find out why ligand binding in PDZ2as is abolished, we completed a 
detailed structural comparison of PDZ2 and PDZ2as. The binding pocket of 
PDZ2as is substantially shorter, shallower and narrower than that of PDZ2, 
with a 4.2 times smaller volume, a 2.9 times smaller mouth size and a 1.2 Å 
narrower base (Table 3.2). In particular, several side-chains now extend into 
the binding pocket, markedly affecting the conformation (Figure 3.4). This 
obstruction can be explained by the differing αB helix positions. In PDZ2, 
βB and αB are mostly parallel, while in PDZ2as, their angles differ by ~30° 
(Figure 3.1D). This causes the N-terminal end of the αB helix to rise and the 
C-terminal end to drop. These changes result in a narrower pocket (Table 
3.2). It is possible that the smaller binding pocket of PDZ2as retains an 
altered specificity for ligands that are able to avoid the problems introduced 
by the increased steric hindrance, such as ligands containing residues with 
smaller side-chains. The fact that similar conclusions were subsequently 
reported for the human PDZ2as domain serves to strengthen these structural 
observations (Kachel et al., 2003). 
 
Because the insert is in very close proximity to the reactive site histidine 
(His 83), we were concerned that its protonation state would be affected, 
preventing the proper interaction with the bound ligand. Thus, we assigned 
the side-chains of all the histidines in PDZ2 and PDZ2as. From the resulting 
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chemical shift data we concluded that all the histidine residues in the two 
domains remain unaffected by the insertion and remain in the Nε2 singly-
protonated state (data not shown). 
  
Structural Effects of Insertions 
The insertion actively disrupts the contacts in the L1 loop, unanchoring it 
from the βE-to-αB turn, and removing several important hydrophobic 
contacts that structured the L1 loop in PDZ2. The relaxation data and amide 
exchange rates clearly show that both the βE-to-αB turn and the L1 loop are 
more flexible, supporting this unanchoring hypothesis. The new 
hydrophobic contacts between βB strand (in particular Val 31) and the βE-
to-αB turn rigidify the base of the binding pocket by replacing one of the 
two glycine-glycine hinges that flanked the L1 loop in PDZ2 with a Val/Leu 
sequence. This hinge was postulated to give the loop an overall slow 
Figure 3.4. Structural changes in PDZ2as. 
(A and B) Comparison of the binding pocket size and shape of PDZ2as (A) with that of 
PDZ2 (B). The size and mouth area of the binding pocket of PDZ2as is smaller than that 
of PDZ2. Residues that form the binding pocket mouth are shaded in transparent gray. 
The backbones of PDZ2as and PDZ2 are visible as Cα traces.  
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dynamic motion, as the large Rex values in the L1 loop of PDZ2 suggest 
(Figure 3.2). This particular section of the L1 loop in PDZ2as is restrained, 
the S2 value of Leu 32 is ~0.1 (or 10%) higher than that of the structurally 
equivalent glycine in PDZ2. In addition, the amides of two inserted residues 
(30 and 32) are more protected than the rest of the βB strand with 
measurable protection factors of 6 and 5.8, also indicating that this region of 
the protein is less exposed to the solvent. We postulate that the displacement 
of this mobile glycine hinge and the introduction of new hydrophobic 
contacts contribute to the abrogation of binding, altering the flexibility of 
the base of the binding pocket and making it less able to accommodate 
ligands. The altered angle of the αB helix also disrupts key contacts across 
the binding pocket, notably between two structurally important residues, Val 
29 and Leu 90. 
 
Insertions and deletions in proteins are most easily accommodated in loops, 
turns and coils because these regions are the most structurally 
accommodative, exposed to solvent and flexible (Pascarella and Argos, 
1992). Therefore, it is not unexpected that the extra residues in PDZ2as 
form part of an extended L1 loop. Other studies have also examined the 
structural and functional roles of loops in proteins. These studies show that 
loop insertions or deletions typically result in minor adjustments to the 
overall protein structure, indicating the propensity of proteins to maintain 
the favorable interactions that are essential to their tertiary structures 
(Ramasubbu et al., 2003; Banerjee et al., 1998; Mossing, 1998). In addition, 
these studies show that the protein counterpart with the longer loop tends to 
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be more unstable than the one with a shorter loop, regardless of which one 
constitutes the wild-type (Ramasubbu et al., 2003; Banerjee et al., 1998; 
Mossing, 1998). For example, it was found that insertions in T4 lysozyme 
destabilized the protein from 1 to 6 kcal/mol (Vetter et al., 1996). 
 
Similar stability results have been acquired for other PDZ domains. The first 
PDZ domain of syntenin contains a four residue-longer L1 loop in 
comparison to its second PDZ domain and this correlates with a lower 
domain stabilization (3.2 vs. 4.8 kcal/mol), higher overall flexibility, a 
narrower peptide binding pocket (1.8 Å narrower at the base), and lower 
affinities for identical ligands (Kang et al., 2003). Likewise, the extension of 
the L1 loop in PDZ2as decreases the overall stability of the domain and 
significantly alters the binding pocket conformation and ligand binding 
abilities. However, this is the first report explaining how intra-domain 
splicing affects the binding properties of a PDZ domain.  
 
Most interestingly, the insert affects the PDZ2 binding properties ‘from a 
distance’; it is not necessary for the five inserted residues in the splice 
variant to physically obstruct the binding pocket to significantly impair this 
domains ligand-binding abilities. Rather, the replacement of the Gly-Gly 
hinge with the more conformationally restricted Val-Leu sequence appears 
to be critical. The insertion results in a higher global flexibility, and an 
adjustment of the hydrophobic core ultimately alters the binding pocket 
conformation and binding properties. Thus, the alternative PDZ2 splice 
variant is an example of nature’s ingenious method to modulate the 
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functional properties of this domain and the current data provide a structural 
and dynamical explanation of these functional differences. 
3.4 Experimental Procedures 
Sample Preparation 
A RT-PCR was performed on mouse lung RNA using the SMART PCR 
cDNA synthesis kit (Clontech), and the cDNA products were used as 
template for a PCR with PDZ2-specific primers. These products were then 
cloned into the pGEM-T vector (Promega). The presence of the 5 residue 
insertion was determined by sequencing. Finally, the PDZ2as domain was 
cloned into a pGEX-2T (Pharmacia) plasmid. Protein expression was 
induced at 37°C under ampicillin selection in Escherichia coli BL21 Codon 
Plus (DE3) RIL competent cells (Stratagene) by the addition of 0.2 mM 
IPTG for 2.5 hours. Uniformly 15N/13C-labelled PDZ2 samples were 
prepared using 1g/l of 15N NH4Cl and 3 g/l 13C glucose as sole nitrogen and 
carbon sources. The cell pellet was resuspended in 1x PBS buffer (pH 7.7) 
in the presence of 1 mM aprotinin, 1 mM PMSF and Complete protease 
inhibitor, sonificated, and then centrifuged twice at 10000 rpm at 4°C for 30 
minutes to remove cell debris. The supernatant was bound to glutathione 
agarose beads (Molecular Probes) and washed with 1x PBS buffer. Elution 
from the column was performed by 15 mM reduced glutathione at pH 7.7. 
To cleave the GST tag, 10U/mL thrombin protease was added in three 
incubations at room temperature, for 18, 5 and finally for 24 hr. This 
mixture of protein was concentrated by first dialysing against water for 24 
hours at 4°C, lyophilizing and finally redissolving in 1x PBS buffer. The 
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resulting mixture was then passed over a Sephadex G75 size exclusion 
column at room temperature and then appropriate fractions were collected, 
dialyzed once more against water overnight, lyophilized and stored at  
-75°C. NMR samples contained ~1.4 mM dissolved protein in a buffer of 50 
mM KH2PO4/K2HPO4 and 50 mM KCl, pH 6.8, H2O/D2O (95%/5%), using 
traces of Complete protease inhibitor and NaN3 as preservatives. The H/D 
amide exchange rate experiments were recorded at 8.5°C using a 1.1 mM 
sample dissolved in a pH 3.5 D2O buffer (50 mM acetate/50 mM KCl). The 
isotropic samples for measuring 1DHN residual dipolar couplings contained 
0.5 mM 13C/15N-labelled protein at pH 9 while aligned samples contained an 
additional 10 mg/mL filamentous Pf1 phage (Asla Labs). The coordinates of 
the PDZ2as ensemble were deposited in the Protein Data Bank under PDB 
code 1ozi and the chemical shifts, 15N relaxation, amide exchange and RDC 
data were deposited in the BioMagResBank under BMRB accession number 
5762. 
 
Peptide Interactions 
The RIL C-terminal peptide contained an N-terminal biotin group and a C-
terminal carboxyl group. The peptide sequences correspond to the final 
twelve C-terminal residues of RIL and the final ten residues of the APC 
(accession numbers NP_062290 and NP_031488). The peptides were 
titrated to more than 3.2 equivalents into individual 1 mM 15N-labelled 
protein samples. The differences in backbone HN and N chemical shifts 
were monitored with 15N-HSQC spectra recorded at 600 MHz and 25°C. 
The vectors of the (initial – final) HN and N frequencies (Hz) vs. the relative 
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concentrations were fit using a least squares procedure to determine 
dissociation constants for the peptides. 
 
NMR Spectroscopy 
NMR experiments were collected at 25°C on a double-labeled 13C/15N 
sample with the exception of the 15N NOESY-HSQC, which was recorded 
on a 15N sample. The NMR experiments were carried out on Varian Unity 
Inova 600 and 800 MHz spectrometers. All data were processed and 
analyzed using the NMRPipe (Delaglio et al., 1995) suite and XEASY 
(Bartels et al., 1995). Resonance assignments were completed using 3D 
HNCA, HNHA, HNCACB, and (H)CCH-TOCSY experiments. The side 
chains of the histidine residues were assigned by firstly correlating the Cβ 
frequency with Cδ2/Hδ3 and secondly correlating the Cδ2/Hδ2 with Nε2, and 
Nε2 with Cε1/Hε1 using constant time/sensitivity enhanced experiments. The 
distance restraints were obtained from an aliphatic 3D 13C NOESY-HSQC 
recorded on a Varian 800 MHz and a 3D 15N NOESY-HSQC (sensitivity 
enhanced) recorded on a Varian 600 MHz, each with mixing times of 100 
ms. 3J(HNHα)-coupling constants were derived from a 3D HNHA 
experiment. 1H-15N residual dipolar couplings were recorded using the 
IPAP-type sensitivity enhanced 15N-HSQC experiments. Peaks were 
reassigned using HNCA experiments. Structurally predicted RDCs were 
calculated using the program MODULE v1.0 (Dosset et al., 2001). Amide 
exchange rates were determined by recording sensitivity enhanced  
15N-HSQC spectra of the pH 3.5 sample at 8.5°C over 144 hours. The rate 
constants for H/D amide exchange were obtained from the peak intensity 
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decay and time data (starting from solvation in D2O buffer). The data was 
non-linearly least-squares fit to a single exponential function using the 
program modelXY (Delaglio et al., 1995). Protection factors were also 
calculated, PF = kint/kobs, where kint is the expected, intrinsic exchange rate 
of a residue at a particular pH and temperature and Kobs is the observed, 
experimental exchange rate. The intrinsic rate constants were determined 
using the program Sphere (Zhang, 1995; Bai et al., 1993). The relaxation 
experiments T1, T1ρ and {1H}15N-NOE were recorded at 25°C at 14.1 T 
(600 MHz). The relaxation delays for the T1 experiments were T = 0.0160, 
0.3840, 0.5120, 0.6400, 1.0240 s. The relaxation delays for the T1ρ 
experiment were T = 0.0160, 0.0320, 0.0480, 0.0960, 0.1120, 0.1280 s. The 
relaxation data were fit using the program Modelfree 4.0 (Mandel et al., 
1995). We determined the isotropic model accurately describes the PDZ2as 
data by fitting the R1/R1ρ of the core residues using the program TENSOR 
(Dosset et al., 2000). 
 
Structure Refinement 
The NOE peak volumes were converted into distance ranges by 
normalization against peak volumes that were calibrated to known distances, 
and then overestimated twofold. Distance restraint ranges were defined with 
lower limits of the van der Waals radii and upper limits of 2.8, 3.5, 5.0 or 
7.0 Å. 76 phi angle restraints were obtained from 3J (HNHα)-couplings. 
Hydrogen bonding restraints were derived from characteristic NOE patterns 
and H/D amide exchange data. The HN-O and the N-O hydrogen bonding 
distances were restrained from 1.2-2.2 Å and 2.2-3.2 Å, respectively. An 
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initial set of 200 NMR structures was calculated using a Cartesian-space 
simulated annealing protocol in X-PLOR version 3.851 (Brunger, 1996). 
This resulted in a set of 73 structures with no distance restraint violations  
> 0.5 Å, dihedral angle violations > 5° or 1DHN residual dipolar couplings 
violations > 0.5 Hz. To improve local geometry and electrostatics, these 73 
structures were then refined in water using a restrained molecular dynamics 
protocol under a CHARMM22 force field (MacKerell et al., 1998; Spronk et 
al., 2002). Of these, the 30 lowest energy structures were selected to form 
the final ensemble. Structures were analyzed using the programs 
PROCHECK-NMR (Laskowski et al., 1996), WHAT-IF (Vriend, 1990), 
QUEEN (Nabuurs et al., 2003). 
 
  
 
Chapter 4 
1H, 13C and 15N resonance assignments of the second PDZ 
domain of PTP-BL in complex with three C-termini from the 
p75NTR, APC and RIL proteins.1 
Summary 
The interaction characteristics of the second PDZ domain of PTP-BL 
with three unique C-termini, from the proteins APC, RIL and 
p75
NTR
, have been determined using NMR. These C-termini 
represent either canonical class 1 or class 3 PDZ-target sequences. 
The changes in chemical shift upon ligand binding indicate that all 
of these ligands interact with PDZ2 in the binding pocket located 
between the βB strand and the αB helix. The data also indicate that 
for all the ligands, structural rearrangements occur within the PDZ2 
domain, particularly involving the αA helix and in the βD-βF face. 
The PDZ2 domain shows additional effects when bound to the APC 
and p75
NTR
 ligands when compared to the RIL ligand and these 
differences correlate with the higher binding affinity of the APC and 
P75
NTR
 C-terminal peptides. 
 
                                                 
1
 van den Berk L, Walma T, Vuister GW and Hendriks W. In preparation. 
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4.1 Biological Context 
It is well documented that many PDZ domains have the capability to bind to 
several related protein sequences with varying affinities (Songyang et al., 
1997; Schepens et al., 1997; Fuh et al., 2000). PDZ domain interactions are 
traditionally classified into four types. Class 1 interactions involve binding 
to S/TxΦ* sequences (where Φ represents a hydrophobic amino acid, ‘x’ 
represents any amino acid and * represents the terminal carboxyl tail), class 
2 involves binding to ΦxΦ* C-termini, class 3 involves binding to E/DxΦ* 
sequences and class 4 involves binding to VxD/E* sequences (Vaccaro and 
Dente, 2002). However, in an attempt to explain the rising number of PDZ 
domains with dual specificities, new methods of classification have also 
more recently been proposed. One method classifies PDZ domains into 25 
subgroups based on the identity of their βB5 and αB1 positions, residues 
which interact with the antepenultimate ligand residue (Bezprozvanny and 
Maximov, 2001). Another categorization system discriminates PDZ-ligand 
binding, not according to explicit ligand residue sequences but rather based 
on the interactions of ligand residues with PDZ surface ‘sites’ (Kang et al., 
2003). In spite of these recent developments, the precise structural 
interactions that govern the specificity of PDZ domains for ligands have not 
yet been clearly determined. 
 
Here, we describe the interactions of PDZ2 of PTP-BL with the C-termini of 
the proteins APC, p75
NTR
 and RIL using high resolution biomolecular 
NMR. To carry out our analysis, we compared the backbone and side chain 
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resonances of PDZ2 while in complex with these class 1 (i.e. APC and 
p75
NTR
) and class 3 (i.e. RIL) protein C-termini.  
4.2 Results  
Figure 4.1 compares the backbone chemical shift differences between the 
PDZ2-ligand complexes and free PDZ2, using both the backbone chemical 
shifts and the chemical shift index (CSI) as monitors (Wishart and Sykes, 
1994). These two measures indicate the effect of ligand binding and 
highlight potential structural changes that occur upon complex formation. 
The CSI relates the chemical shifts of 
1
H and 
13
C nuclei in folded proteins to 
those obtained for random coil proteins. For example, in an α-helical 
structure, H
α
 protons show an average 0.39 ppm upfield shift while those in 
a β-strand structure show an average 0.37 ppm downfield shift with respect 
to the random coil situation. 
 
For each complex, the largest shifts occur for residues located in the βB 
strand and αB helix, implying that the peptides bind in the canonical binding 
pocket. However, from Figure 4.1 it is also clear that other residues outside 
the direct binding site show significant changes upon complex formation. 
For example, residues within the αA helix display significant effects (i.e 
residues 53 and 54). These changes can be attributed to a structural change 
that occurs upon complexation due to the close proximity of αA helix to the 
carboxylate binding loop in the binding pocket. In addition, Asn 69 shows 
very large chemical shift changes in all three complexes. This residue is 
located on the βD-βF face, opposite to the binding pocket. The CSI indicates 
that the conformation of this region of the protein adopts a more uniform  
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β-sheet structure while in a complexed form. The closest and mostly likely 
interaction partner for this Asn 69 is the cross-strand carboxyl of His 93 in 
the βF strand. Being part of the βD strand, Asn 69 hydrogen bonds to  
His 93, augmenting an extended sheet across the rear of the domain. 
 
Figure 4.1. The interaction of PDZ2 with C-termini from the proteins RIL, p75NTR and 
APC. The three bottom panels display the changes in 1H and 15N backbone chemical shifts 
observed in PDZ2 upon complex formation with RIL, p75NTRand APC C-terminal ligands, 
respectively. The HN and N vectors were scaled, see text for details. The changes in 
chemical shift of Hα, Cα and Cβ in PDZ2 upon complex formation are summarized by the 
changes in CSI secondary structure displayed in the top four panels (Wishart and Sykes, 
1994). At top, the secondary structure of the free PDZ2 domain is displayed, as determined 
from the ensemble 1GM1 (Walma et al., 2002; Chapter 2). 
 
The patterns of the CSI suggest that the binding of the ligand along the βB 
strand promotes more β-strand character in the βB-βC sheet. The interaction 
of the carboxylate binding loop with the ligand also appears to affect the 
conformation of the αA helix, as indicated by the changes in CSI for the 
strongest binding ligands, APC and p75
NTR
. 
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Monitoring the resonance positions of selected peaks as a function of 
increasing peptide concentration allows for the determination of the 
dissociation constants for the three PDZ2-ligand complexes (see the 
experimental procedures section for details). Figure 4.2 shows the changes 
in chemical shift upon binding a ligand for the residue Gly 26. The largest 
changes are observed for the higher affinity APC ligand and the smallest 
changes for the lower affinity APC ligand. From these data, the dissociation 
constants were calculated to be 0.19, 0.3 and 1.4 mM for the APC, p75
NTR
 
and RIL ligands, respectively. The different affinities are also reflected in 
the pattern of chemical shift differences, as displayed in Figure 4.1. The 
interaction of the higher affinity APC and p75
NTR
 ligands results in larger 
overall chemical shift differences when compared to the lower affinity RIL 
counterpart. 
 
Figure 4.2. Titration curve of Gly 26, a key residue in the carboxylate binding loop. The 
change in chemical shift of Gly 26 upon complex formation with the APC (black), p75NTR 
(dark gray) and RIL (light gray) ligands is shown. Curves are least-squares fit to the 
theoretical binding curve, listed in the Experimental Procedures section. 
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4.3 Discussion 
We have characterized the interaction of the PDZ2 domain with three  
C-terminal ligands, displaying affinities ranging from 0.19 to 1.4 mM. The 
ligand affinities also correlate with the observed range of chemical shift 
differences. Ligands with higher affinities display larger chemical shift 
differences for identical residues. Detailed analysis also shows that ligands 
with higher affinities interact with a greater number of PDZ2 residues than 
do ligands with lower affinities. This is particularly noticeable in the lower 
portions of βB and the αB helix, which show significant effects resulting 
from the p75
NTR
 and APC, effects which are not obvious in the RIL 
complex. It is significant to note that APC and p75
NTR
 are class 1 
interactions while RIL is a class 3 interaction, and that the differential 
effects are therefore to be expected. 
 
The dissociation constants for the PDZ2 protein domain are all in the high 
µM to low mM range. These affinities are low for protein-protein 
interactions; however, this level of affinity is consistent with the transient 
nature of intracellular protein complexes. The affinities are high enough to 
attract and selectively bind interaction partners yet still weak enough to 
allow the binding partner to disengage after other biologically important 
interactions have taken place. An additional point to consider is that these 
interactions normally occur between full-length proteins and the effects of 
auxiliary proteins within a larger biological context may also result in higher 
affinities. 
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Our results can also be compared to those of the human PDZ2 domain 
interacting with a C-terminal ligand from the RA-GEF-2 protein (Kozlov et 
al., 2002). The human PDZ2 domain shares 94% sequence homology with 
the mouse PDZ2 domain, and both possess very similar interaction 
properties. Analysis of 
15
N and 
13
C relaxation data of this domain indicates a 
structural cooperativity upon ligand binding, similar to that of the mouse 
PDZ2 domain. Whereas our chemical shift data show that ligand binding 
affects the conformation of Asn 69 and His 93, it was shown that the 
formation of human PDZ2-RA-GEF-2 complex affects the relaxation of the 
directly adjacent residues Val 68 and Val 92 residue (numbering as in the 
mouse PDZ2 domain) (Fuentes et al., 2004). Other similarities between the 
two domains also exist. For example, the human PDZ2-RA-GEF-2 complex 
exhibits altered relaxation properties for Ala 66 and Ile 47 at the C-terminal 
end of βC strand, an area that also is perturbed by ligand binding in our 
studies (see Figure 4.1). 
 
The results of these relaxation studies and our own titration studies bear 
remarkable similarity to the pattern of energetic couplings described for the 
αB1 residue in the PDZ3 domain of PSD-95 (equivalent to His 78 in PDZ2) 
(Lockless and Ranganathan, 1999). The latter demonstrated that the αB1 
residue is energetically and thermodynamically coupled to distal residues in 
the PDZ domain. The similarity of the distal couplings to the PDZ2-ligand 
interactions we report here, and also to those of the human PDZ2 –  
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RA-GEF-2 complex, suggest that PDZ domains possess an internal 
energetic connectivity that is intrinsically related to their tertiary structure 
(Lockless and Ranganathan, 1999).  
 
This internal connectivity suggests that PDZ domains could be subject to 
allosteric effects and indeed, allosterism has been demonstrated for the Par6 
and GRIP proteins. The interaction of the Par6 CRIB domain with another 
protein allosterically regulates the affinity of the adjacent PDZ domain for 
its ligand, increasing the affinity by ~13-fold (Peterson et al., 2004). The 
CRIB domain modulates this change in affinity by contacting αA helix of 
the PDZ domain, which then alters the flexibility of the carboxylate binding 
loop and the orientation of the αB helix, promoting a high-affinity 
conformation (Peterson et al., 2004). Tandem PDZ domains in GRIP protein 
were also shown to possess allosteric connectivity. The PDZ4 domain is 
connected to the PDZ5 domain by a short linker, stabilizing the structure of 
PDZ5 and allowing it to bind peptides (Feng et al., 2002). In a surprisingly 
similar mechanism to Par6, this effect is transmitted by the surface packing 
of PDZ4 and the linker onto the surface formed by the αA, βA-to-βB loop 
and βC-to-αA loop in PDZ5 (Feng et al., 2002). 
 
In conclusion, the APC, p75
NTR
 and RIL ligands bind to PDZ2 similarly, 
namely, in the canonical binding pocket located between the βB strand and 
the αB helix. In addition, other regions of the PDZ domain are significantly 
affected by ligand binding, for example, the αA helix. It appears that the 
structural rearrangement of PDZ domains upon ligand binding is a 
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mechanism common to many PDZ domains. In PDZ2, we observe that 
ligand affinity is also related to the category of interaction: class 1 
interactions show higher affinities than class 3 interactions. Determining the 
characteristics that differentiate between higher and lower affinity 
interactions would help to elucidate the structural requirements that govern 
PDZ-ligand interactions. 
4.3 Experimental Procedures 
The preparation and expression of the PDZ2 protein domain was previously 
described (Walma et al., 2002; Chapter 2, 2004). The NMR samples 
contained ~1 mM uniformly labeled 
15
N/
13
C PDZ2 protein in a buffer 
consisting of 50 mM KH2PO4/K2HPO4 and 50 mM KCl, pH 6.8, H2O/D2O 
(95%/5%) and trace amounts of NaN3. Unlabeled peptides titrated into 
PDZ2 domain-containing sample until the 
15
N-HSQC spectra of PDZ2 
showed no further changes, with final peptide concentrations ranging from 
2.4 to 3.2 mM. Each peptide contained an N-terminal biotin group and a  
C-terminal carboxyl group (Ansynth Service BV, Roosendaal). The peptide 
sequences corresponded to the final nine or twelve C-terminal residues of 
three proteins, APC (-KRHSGSYLVTSV*), RIL (-VAVYPNAKVELV*) 
and p75
NTR
 (-SESTATSPV). NMR experiments were recorded at 25°C. The 
sequential assignments were completed using 3D HNCA and CCH-TOCSY 
experiments recorded on either Varian Inova 500 or 600 spectrometers. The 
sidechains of histidine residues were assigned, firstly by correlating the C
β
 
frequency with C
δ2
/H
δ3
 and secondly correlating the C
δ2
/H
δ2 
with N
ε2
, and 
N
ε2
 with C
ε1
/H
ε1
, using constant time/sensitivity enhanced experiments. All 
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spectra were processed using the NMRPipe program suite (Delaglio et al., 
1995) and assigned using XEASY (Bartels et al., 1995). 
 
Dissociation constants 
The interactions between the three ligands and the PDZ2 domain were 
followed by NMR. The differences in backbone H
N
 and N chemical shifts in 
the PDZ2 domain upon titration with the C-terminal ligands were monitored 
using 
15
N-HSQC spectra, recorded on the equilibrated samples at 600 MHz 
and 25°C. The C-terminal peptides were titrated into separate 1 mM PDZ2 
samples, composing of a buffer of 50 mM KH2PO4/K2HPO4 and 50 mM 
KCl, pH 6.8, H2O/D2O (95%/5%) at pH 6.8. The difference in chemical 
shift were calculated according to the equation (| ∆H
N
 + 0.2*∆N| ). The  
| initial – final | H
N
 frequencies (Hz) and relative concentrations were fit 
using a least squares procedure to determine dissociation constants for the 
three ligands, according to the equation CSobs = ([ligand] * CSmax) / 
([ligand] + Kd ), where Kd is the dissociation constant, CSobs is the observed 
chemical shift, CSmax is the calculated maximum chemical shift, [ligand] is 
the concentration of the ligand relative to that of the PDZ2 domain. The 
final fits and errors yielded Kd values for the APC, p75
NTR
 and RIL peptides 
to be 0.19 ± 0.1 mM, 0.3 ± 0.2 mM and 1.4 ± 0.4 mM, with respective 
CSmax values to be 380 ± 29 Hz, 312 ± 60Hz and 301 ± 41 Hz. 
 
Deposition 
Backbone 
1
H, 
15
N and 
13
C assignments have been obtained for the APC, 
RIL and p75
NTR
 peptide-PDZ2 complexes. In all cases, the H
N
, N and C
α
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resonances were assigned to more than 95% completeness. In addition, for 
the APC and RIL peptide complexes, the sidechain assignments were 
completed to > 86% completeness. The APC, RIL and p75
NTR
 assignment 
sets have been deposited in the BioMagResBank under accession numbers 
6060, 6091 and 6092, respectively. A detailed analysis of the sidechain 
chemical shifts is presented in Chapter 6. 
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Chapter 5 
The interaction of PDZ2 of PTP-BL with the LIM domain-
containing protein RIL is mediated by the RIL C-terminal tail.1 
Summary 
An interaction between the RIL-LIM domain and PDZ2 of PTP-BL 
has been proposed on the basis of yeast-two hybrid experiments. In 
order to more fully describe this interaction, we expressed two 
versions of the RIL-LIM domain, the first containing the LIM 
domain alone and the second, the LIM domain plus its intact  
16-residue C-terminal tail. We used NMR to characterize the 
interactions of these two protein fragments with the PDZ2 of PTP-
BL and also to compare them to the interaction with the RIL  
C-terminal peptide. We show that the LIM domain, in combination 
with an intact C-terminus, interacts with the PDZ2 domain very 
similarly to the C-terminal peptide. In contrast, the LIM domain 
alone does not interact with the PDZ2 domain in vitro. These data 
are in line with a canonical type of interaction for PDZ2 and the 
carboxyl terminal tail of RIL. 
                                                 
1
 As reported in: van den Berk L, van Ham M, te Lindert MM, Walma T, Vuister 
GW, and Hendriks W (2004) . The interaction of PTP-BL PDZ domains with RIL: 
An enigmatic role for the RIL LIM domain. Molecular Biology Reports. Submitted. 
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5.1 Introduction 
Mouse PTP-BL is a large cytosolic protein with several protein-protein 
interaction domains. The many protein names within the PTP-BL family 
reflect the origins of discovery. Originally cloned from a basophil cell line, 
the human protein was given the name PTP-BAS (Maekawa et al., 1994). 
Independently, this protein was also cloned in human glioma cell line and a 
human breast carcinoma cell line, and additionally given the names hPTP1e 
and PTPL1 (Banville et al., 1994; Saras et al., 1994). Finally, its interaction 
with the Fas receptor led to the name FAP-1, standing for Fas-associated 
protein (Sato et al., 1995). The mouse orthologue was also independently 
isolated in different laboratories and named RIP (receptor-interacting 
protein) and PTP-BL (for BAS-like) (Chida et al., 1995; Hendriks et al., 
1995). 
 
Both the human and mouse versions of the protein PTP-BL contain a KIND 
domain, a FERM domain, five PDZ domains and a C-terminal protein 
tyrosine phosphatase catalytic domain (Figure 5.1). The interactions 
reported for each domain in PTP-BL are summarized in Chapter 1, but for 
completeness, the interactions for the five PDZ domains are briefly 
summarized below. 
 
 
Figure 5.1. Schematic of the protein PTP-BL. The KIND, FERM, PDZ and PTP domains, 
separated by flexible linker regions. 
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PDZ domain Interactions 
The five PDZ domains in PTP-BL bind to proteins with diverse functions. 
PDZ1 has been reported to interact with IκBα (Maekawa et al., 1999), the 
tandem PH domain-containing proteins TAPP1 and TAPP2 (Kimber et al., 
2003) and BP75 (Cuppen et al., 1999). PDZ2 interacts with the tumor 
suppressor protein APC (Erdmann et al., 2000) and with p75
NTR
 (Irie et al., 
1999). In addition, PDZ2 and PDZ4 interact with two LIM domain-
containing proteins, RIL and TRIP-6 (Cuppen et al., 2000), which are found 
at actin-rich structures in the cell, and also with the human Fas/CD95 
receptor (Sato et al., 1995; Cuppen et al., 1997; Saras et al., 1997a). PDZ3 
interacts with the Rho effector kinase PRK2 (Gross et al., 2001). PDZ4 
interacts with the Rho-GAP PARG1 (Saras et al., 1997b) and with B class 
ephrins (Lin et al., 1999). No proteins are known to interact with PDZ5, 
although along with the PDZ2 and PDZ3 domains, PDZ5 is capable of 
interacting with the phospholipid PIP2 (Zimmermann et al., 2002). This 
lipid competes with C-terminal ligands for binding and it was suggested that 
PTP-BL might have a function as a lipid transporter (Kachel et al., 2003).  
 
The distinct specificities of the five PDZ domains of PTP-BL are reflected 
by their different amino acid sequences, shown in Figure 5.2. The most 
variation between the domains occurs in the L1 loop, with lengths varying 
from 5 to 12 residues. The most conserved residues are either small residues 
involved in turns or hydrophobic residues involved in maintaining the 
structural integrity of the domain. These residues face inward into the 
protein core, as alignment with the structure of PDZ2 suggests (see Chapter 
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2 for details on the structure of PDZ2 and Chapter 6 for further details on 
the structural alignment of PDZ domains). Residues that are critical for 
ligand binding, such as those in the carboxylate binding loop between βA 
and βB, also reflect binding preferences. Two PDZ domains, PDZ2 and 
PDZ4, are known to bind similar peptides and this is reflected by the 
sequence similarity of their carboxylate binding loops, -SLGI- and –SLGF-, 
respectively. 
 
 
Figure 5.2. Sequence Alignment of the five PDZ domains of PTP-BL. The secondary 
structure of PDZ2 is indicated at the top. Identical (*), highly conserved (:) and conserved 
(.) residues are indicated at the base. 
 
In general, PDZ domains have been classified as binding four different 
types of C-terminal sequences (Songyang et al., 1997; Vaccaro and Dente, 
2002). An additional type of interaction involves PDZ binding to internal 
sequence motifs, as exhibited by the PDZ-PDZ dimerization interaction 
between syntrophin and nNOS (Hillier et al., 1999). Over the past years, 
several other alternative internal peptide targets for PDZ domains have been 
discovered (Maekawa et al., 1999; Siemens et al., 2002; Xia et al., 2000; 
Tochio et al., 2000; Hurd et al., 2003; Lou et al., 2001; Wong et al., 2003). 
The interaction of a PDZ domain with a LIM domain (Cuppen et al., 1998) 
may exemplify yet another type of alternative interaction. 
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LIM Domain Interactions 
It was previously reported on the basis of yeast two hybrid pull down 
experiments that the protein PTP-BL interacts with the proteins RIL and 
TRIP-6 via a PDZ domain/LIM domain interaction (Cuppen et al., 1998; 
Cuppen et al., 2000). In particular, it was found that deletion of the extreme 
RIL C-terminus did not eliminate binding, which suggested the presence of 
a PDZ binding site within the RIL LIM moiety (Cuppen et al., 1998). A 
schematic diagram describing the interactions determined by yeast-two 
hybrid studies is shown in Figure 5.3. However, it was subsequently shown 
by NMR experiments that the isolated RIL C-terminus is capable of 
interacting with the PDZ2 domain (Walma et al., 2002; Chapter 2).  
 
  
Like PDZ domains, LIM domains act as interfaces in protein-protein 
interactions. LIM domains contain two zinc atoms bound independently in a 
CCHC (C = Cys, H = His, D= Asp) and CCC(C/H/D) double zinc-finger 
motif. The zinc atoms maintain the structural integrity of this double  
β-finger structure (Perez-Alvarado et al., 1994; Khurana et al., 2002).  
Figure 5.3.Schematic outline of some reported intracellular interactions involving PTP-
BL using yeast-two hybrid methodology (Walma et al., 2002)
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We chose to more fully examine the interaction of the C-terminal half of the 
RIL protein (containing the LIM domain) with PDZ2 of PTP-BL. The RIL 
protein was originally discovered because of its downregulation in H-ras-
transformed fibroblasts (Kiess et al., 1995). It was further found to be 
upregulated in cells transformed by v-Jun, an oncogene product (Fu et al., 
2000). The RIL gene resides in a region that is frequently deleted in the 
malignant cells of patients with myelodysplasia and myeloid leukemia 
(Bashirova et al., 1998) and recent cell biological studies have demonstrated 
a role in the modulation of actin stress fiber turnover (Vallenius et al., 
2004). Finally, mutations in RIL have been linked to low bone mineral 
density in adult Japanese women (Omasu et al., 2003). 
 
Because of the potential novel nature of the PDZ-LIM interaction, we 
investigated the interactions of the RIL LIM domain with the PDZ2 domain 
of PTP-BL. We produced two different fragments of the C-terminal half of 
the RIL protein containing the LIM domain. The protein fragments either 
included or lacked the C-terminus proper, and we carefully monitored and 
compared the patterns of these two interactions at a sequential level using 
NMR spectroscopy. 
5.2 Results 
LIM domains are notorious for being insoluble and unfolded after over-
expression in E. coli cells, a process essential to obtain the high protein 
concentrations necessary for analysis by NMR spectroscopy. This problem 
arises from the difficulty of maintaining the proper coordination of the zinc 
in its structure. Therefore, before we analyzed the interactions, we recorded 
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two 2D NOESY solution spectra of both RIL protein fragments. The spectra 
of both forms of LIM domain exhibit a clear dispersion of peaks, 
demonstrating that these proteins were folded and soluble at the conditions 
used in the NMR experiments, indicating that the overexpression and 
purification procedures were successful. 
 
Figure 5.4. Excerpts of the 2D NOESY solution spectra of the 
(A) recombinant RIL LIM domain alone and the 
(B) RIL LIM domain including an intact C-terminus. Both spectra show a clear dispersion 
of peaks in the amide region. 
 
The interaction of the RIL LIM domain plus the C-terminus and the LIM 
domain alone was compared to the previously determined interaction of the 
RIL C-terminal peptide, which was used as a positive binding control 
(Walma et al., 2002). The interactions were characterized monitoring the 
peak differences of 
15
N-labelled PDZ2 in 
15
N HSQC spectra. For reference, 
the interaction of PDZ2 with the RIL C-terminus is shown in Figure 5.5A. 
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The complex formed between PDZ2 and the RIL C-terminal peptide 
exhibits fast exchange with their free components, and very specific 
interactions. Key residues in the binding pocket shift along with the 
increasing concentration of the RIL C-terminus. The most noticeable effects 
include residues such as Gly 26 and Arg 86, as indicated in Figure 5.5A. 
These residues are involved in binding the most C-terminal valine residue 
by hydrogen bonding interactions with the carboxylate group and by 
hydrophobic interactions with the valine sidechain (see Chapter 6 for 
details). The dissociation constant for the PDZ2-RIL C-terminus interaction 
was determined to be ~1.4 mM (Walma et al., 2002; Chapter 2; Chapter 4). 
 
In Figure 5.5B, the interaction of PDZ2 with the RIL LIM domain including 
its complete C-terminus is displayed. As with the C-terminus alone, the 
residues in the canonical ligand binding pocket display the most changes in 
chemical shift. This indicates that the C-terminus, and not the LIM domain 
itself, is the major binding determinant in this interaction. For example, 
peaks representing Gly 26 and Arg 86 are not visible in the spectrum 
because the interaction of the PDZ2 domain with the LIM domain-
containing protein segment causes an intermediate exchange effect. 
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Figure 5.5. Three sets of 
overlaid 15N-HSQC  
solution spectra recorded 
on uniformly 15N labeled - 
PDZ2 domain in the 
presence of various 
fragments of the RIL 
protein. Black peaks  
originate from the native 
PDZ2 domain, whereas 
peaks in varying shades of 
grey originate from 
increasing ratios of 
RIL:PDZ2 concentrations. 
(A) The PDZ2 domain in 
presence of the final 12 C-
terminal residues of the 
RIL protein. Peaks that 
are strongly are affected 
are indicated by arrows,  
(B) The PDZ2 domain in 
the presence of the RIL 
fragment including both 
the LIM domain and the 
intact C-terminus. The 
pattern of affected 
residues is similar to the 
RIL C-terminus. Circles 
indicate where peaks 
disappear completely (Gly 
26 and Arg 86). 
(C) The PDZ2 domain in 
the presence of the RIL-
LIM domain alone 
(excluding the final 16 
residues comprising the 
C-terminus). No peak 
shifts or change in peak 
intensity upon the titration 
of the two domains was 
observed. 
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To confirm that the PDZ2-LIM interaction is predominantly mediated by 
the RIL-C-terminus, we also performed a titration of the PTP-BL PDZ2 
domain with the RIL LIM domain without the C-terminus present. Figure 
5.5C shows the resulting spectrum. Over the course of the titration, no peak 
shifts or intensity changes are visible, indicating that the interaction of the 
LIM domain with the PDZ2 domain is too weak to be detected by NMR. 
5.3  Discussion 
The interaction of PDZ2 with the LIM domain-containing half of RIL was 
initially detected by yeast-two hybrid interactions and results suggested that 
the PDZ binding site was within the RIL LIM moiety (Cuppen et al., 1998). 
PDZ domains had been described previously as interacting with 
unstructured protein C-termini. A structural description of the PTP-BL 
PDZ2- RIL LIM interaction would broaden the known binding capabilities 
of the PDZ protein domain family. 
 
The NMR titration data of the interaction show that the C-terminus of RIL 
interacts positively with PDZ2 and a Kd of 1.4 mM was derived for this 
interaction. These NMR data also show that this interaction is able to occur 
when a LIM domain is attached to the C-terminus. Both interactions involve 
similar PDZ2 residues, demonstrating that the C-terminus is able to interact 
with PDZ2 even when attached to an intact LIM domain. An analysis of the 
LIM domain alone together with the PDZ2 domain did not reveal any 
effects that could have suggested a direct interaction between the two 
domains. 
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Both yeast two hybrid studies and protein association studies in mammalian 
cells have consistently shown that the interaction between the RIL and  
PTP-BL proteins is stronger when both the LIM domain and the intact  
C-terminus are present (van den Berk et al., 2004). In addition, these studies 
also show that a homologous LIM domain derived from the related protein 
ALP in a chimera with the RIL C-terminus can fulfill the same role as the 
RIL-LIM domain (van den Berk et al., 2004). However, our NMR titration 
experiments combined with site-directed mutagenesis (van den Berk et al., 
2004) indicate that the association between the RIL and PTP-BL proteins 
does not involve specific interactions between the PDZ2 domain and the 
RIL-LIM domain. In combination, these results suggest that the RIL- 
C-terminus binds in a canonical manner to the PTP-BL protein, but that the 
interaction is enhanced by an as yet undefined synergistic contribution of 
the LIM domain (van den Berk et al., 2004). 
 
In light of these results, it is possible to visualize a scenario where the LIM 
domain interacts with an interface formed by the multiple PDZ domains 
from PTP-BL. This interaction could be enhanced by a summation of 
multiple weak interactions between pseudo-peptide binding sites within the 
LIM domain and the PDZ domains of PTP-BL (van den Berk et al., 2004). 
Our alternate theory postulates that in the full cellular context, the LIM 
domain itself stabilizes the structural presentation of its own C-terminus, 
optimizing its interaction with PTP-BL PDZ domains (van den Berk et al., 
2004). 
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These results, in combination with our NMR data indicate that the LIM-
PDZ interaction is more complex then originally thought, consisting of a 
multifaceted interaction between the two domains. Despite the complexity 
of the interaction scenario, it remains clear that the RIL C-terminus mediates 
a canonical PDZ interaction with PTP-BL and the RIL LIM domain 
provides an as of yet unclarified, positive contribution to the interaction 
affinity between the two proteins. 
5.4 Experimental Procedures 
The PDZ2 protein domain contained 8 residues of a His tag (Met + 6 His + 
Met) and 94 residues encompassing the domain (residues 1351 to 1444, 
accession number NP_035334) inserted into a modified pET28a plasmid 
vector (Hoffmann et al., 1997). Protein expression was induced at 37°C 
under kanamycin selection in Escherichia coli BL21(DE3) cells by addition 
of IPTG for 4 hours. The cell pellet was resuspended in a HEPES buffer  
(pH 7) in the presence of protease inhibitors, sonificated, and then 
centrifuged twice at 10000 rpm for 30 minutes to remove cell debris. The 
supernatant was passed through a Ni
2+
-NTA agarose column (Qiagen) and 
bound protein was first washed with 20 mM imidazole and eluted with  
500 mM imidazole in a pH 7.9 HEPES buffer. Selected fractions were 
diluted and run through a S-sepharose fast flow cation exchange column 
(Amersham Pharmacia), from which the protein was eluted using a 0-1M 
NaCl gradient in a pH 7 HEPES buffer. Fractions containing the protein 
were then dialyzed against water, lyophilized and stored at -75°C.  
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The complete RIL LIM domain including an intact C-terminus (82 residues, 
numbers 249-330, accession number NP_062290) and the LIM domain 
proper (lacking the final 16 C-terminal residues of RIL) were expressed as 
GST fusion proteins using a pGEX2T vector at 37°C under ampicillin 
selection in Escherichia coli BL21 Codon Plus (DE3) RIL competent cells 
(Stratagene) by the addition of 0.2 mM IPTG for 2.5 hours. Care was taken 
to ensure that all further isolation procedures occurred in the presence of  
1 mM zinc sulfate and at a pH below 7. The cell pellet was resuspended in 
1x PBS buffer (pH 6.5) in the presence of 1% sarcosyl detergent, 1 mM zinc 
sulfate, 1 mM aprotinin and 1 mM PMSF. To dissolve the pellet, lysozyme 
was added at a concentration of 1 mg/mL, and the resulting mixture was 
centrifuged twice at 10000 rpm at 4°C for 30 minutes to remove cell debris. 
The supernatant was bound to glutathione agarose beads (Molecular Probes) 
and washed with 1x PBS buffer. Elution from the column was performed by 
15 mM reduced glutathione at pH 6.75. To cleave off the GST tag, 10U/mL 
thrombin protease was added in for ±18 h at 4°C. The resulting mixture was 
then passed over a Sephadex G75 size exclusion column at room 
temperature and then appropriate fractions were collected, and dialyzed 
against excess water or an appropriate buffer overnight at 4°C. The  
C-terminal peptide corresponded to the final 12 residues of the RIL protein, 
-VAVYPNAKVELV* (Walma et al., 2002) and was ordered from Ansynth 
Service BV (Roosendaal), containing an N-terminal biotin tag and free C-
terminal carboxyl group. 
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NMR 
The interactions between the two LIM domains and the PDZ2 domain were 
monitored using NMR spectroscopy. The differences in backbone 
1
H
N
 and 
15
N chemical shifts in the PDZ2 domain upon titration with the LIM 
domains were monitored using 
15
N-HSQC spectra, recorded on the 
equilibrated samples at 600 MHz and 25°C. For direct comparison of the 
different spectra displayed in Figure 5.5, those of Figure 5C required post-
acquisition unfolding to compensate for the differences in sweep width 
along the indirectly detected 
15
N dimensions. Spectra are overlaid in black 
and gray scales: black indicates PDZ2 in the absence of RIL while shades of 
gray reflect increasing ratios of RIL to PDZ2. The C-terminal peptide was 
titrated up 3.5 equivalents into a 1 mM PDZ2 sample, composing of a buffer 
of 50 mM KH2PO4/K2HPO4 and 50 mM KCl, pH 6.8, H2O/D2O (95%/5%). 
A sample of 400 µL of 0.5 mM of the complete LIM domain, including an 
intact C-terminal region, was prepared in a pH 6.8 buffer of 50 mM 
KH2PO4/K2HPO4 and 50 mM KCl, H2O/D2O (95%/5%). Labeled PDZ2 was 
added until 1.84 equivalents. A sample of 0.5 mM of the LIM domain only, 
exclusive of the final 16 C-terminal residues, was prepared at pH 6.3, and 
labeled PDZ2 domain was titrated up until 1.2 equivalents. 
 
  
 
Chapter 6  
A structure-based approach to PDZ-ligand interactions 
suggests a novel classification scheme: an example of the 
interaction of PDZ2 of PTP-BL with the APC and RIL C-terminal 
ligands.1 
Summary 
The structure of the second PDZ domain (PDZ2) of the tyrosine 
phosphatase PTP-BL in complex with the C-terminal ligand from the 
tumor suppressor protein APC is reported. Comparison of the data 
obtained for this complex with data obtained for a PDZ2-RIL 
complex indicates that the presence and absence of interactions of 
the penultimate residues helps to explain their differences in 
affinities. An in-depth structural analysis of eight different PDZ-
ligand complexes shows that interactions with the penultimate 
position determine those of subsequent ligand residues, and that at 
least the final four C-terminal residues must be considered in the 
PDZ binding motif. We propose a structure-based categorization of 
PDZ domain-ligand interactions that considers the interaction of the  
P-1 ligand residue with the second, fifth and seventh residues of the 
βC strand in the PDZ domain as crucial classifying elements. The 
                                                 
1
Walma, T and Vuister GW. In preparation. 
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proposed model allows for the predictive classification of PDZ 
domains and is capable of rationalizing the relative affinities of PDZ 
domains for different C-terminal ligand targets. 
6.1 Introduction 
PDZ domains form a compact globular fold composed of six β strands 
(denoted as βA to βF) and two α helices (denoted as αA and αB), as 
displayed in Figure 6.1 (Harris and Lim, 2001; Hung and Sheng, 2002; Jelen 
et al., 2003; Nourry et al., 2003; Sheng and Sala, 2001). The six β strands 
form two anti-parallel β sheets that stack onto each other. The discovery that 
PDZ domains recognize protein C-terminal motifs (Kim et al., 1995; 
Kornau et al., 1995; Matsumine et al., 1996) was followed by a report 
detailing the structure of the third PDZ domain of PSD-95 in complex with 
a C-terminal peptide ligand, consequently describing the general recognition 
mechanism of PDZ domains (Doyle et al., 1996). These results set the tone 
for future discoveries by proposing that PDZ domains recognize ligands in a 
sequence-dependent manner, primarily involving the terminal and 
antepenultimate residues of ligands (designated P0 and P-2), and terming the 
P-1 residue ‘functionally unimportant and poorly conserved’ (Doyle et al., 
1996).  
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Carboxylate
    binding
          loop
 
Figure 6.1. The topology of a PDZ domain. The secondary structures are labeled 
sequentially according to their position relative to the N-terminus. Rectangular cubes 
represent β-strands while cylinders represent α-helices. Ligands (arrow) canonically bind 
between the βB strand and αB helix. The L1 and carboxylate binding loops are also 
indicated. 
 
As Figure 6.1 illustrates, the C-terminal residue of the ligand is ensconced 
in a hydrophobic pocket formed by the side chains of residues in the βB 
strand and αB helix. N-terminal to the βB strand is the so-called carboxylate 
binding loop which contains the signature GLGF sequence and adopts a 
unique conformation. This loop juxtapositions several backbone amides to 
coordinate the carboxylate terminus of bound ligands, while a conserved 
Arg/Lys residue in this βA-to-βB turn donates a proton via a water molecule 
to stabilize the ligand’s negatively charged end (Doyle et al., 1996). The 
sidechains of more N-terminal ligand residues also confer specificity. The 
most commonly reported interactions describe a serine or threonine residue 
at the P-2 ligand position sharing an exchangeable side chain proton, 
provided by a histidine at the first position of the αB helix, also termed αB1 
(Doyle et al., 1996). Other reports show that a hydrophobic residue at the P-2 
position interacts with a second hydrophobic pocket, formed by three 
residues in the lower portions of the βB strand and αB helix (Daniels et al., 
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1998). In addition, other interactions involving residues down to the P-7 
position have been described (Birrane et al., 2003) and even dependencies 
on residues P-8 and P-10 have been reported (Cai et al., 2002). At the lower 
end of the binding pocket is a variable-length loop L1, which has been 
shown to regulate ligand binding in the second PDZ domain of the tyrosine 
phosphatase PTP-BL (PDZ2) (Walma et al., 2004; Chapter 3). 
 
Classification of PDZ domains 
Several attempts have been made to classify PDZ domains and their 
repertoire of interactions. PDZ domains were first grouped into two classes 
based on an empirical characterization of their ligand sequences by means 
of oriented peptide libraries (Songyang et al., 1997). Class 1 interactions 
were defined to involve ligands containing S/T-x-Φ* sequences and class 2 
interactions to involve ligands containing F/Y/R-x-Φ* sequences (where Φ 
represents hydrophobic amino acids, ‘x’ refers to any amino acid, and * 
denotes the terminal carboxylate group). An additional class 3 was 
introduced after PDZ domains in nNOS and PTP-BL were found to bind 
D/ExΦ* sequences (Schepens et al., 1997; Walma et al., 2002; Chapter 2), 
and a further fourth class was created to accommodate reports of PDZ 
domain ligands containing -xψD/E* sequences, (where ψ represents any 
hydrophilic amino acid) (Vaccaro et al., 2001). 
 
Other methods of classifying PDZ domains have also been recently 
proposed. One method classifies PDZ domains into 25 subgroups based on 
the identity of their βB5 and αB1 positions, residues which interact with the 
Chapter 6  113 
 
antepenultimate ligand residue (Bezprozvanny and Maximov, 2001; 
Bezprozvanny and Maximov, 2002). This system provides an unbiased 
model that is able to make computational use of sequence databases. 
However, critics charge that classifying PDZ domains on the basis of two 
residues alone is not sufficient and that empirical characterization remains 
the safest approach (Vaccaro and Dente, 2002). 
 
A second, alternative categorization system describes PDZ-ligand binding 
not as depending explicitly on the ligand or PDZ sequence, but rather on the 
interactions of individual ligand residues with a succession of smaller PDZ 
surface ‘sites’ (Kang et al., 2003a). This categorization system recognizes 
that the classification of PDZ-ligand complexes depends on the sequence 
identities of both interacting partners and raises the possibility that a single 
PDZ domain can belong to two interaction categories, behavior that has 
been previously observed for the second PDZ domain of the proteins 
syntenin and PTP-BL (Kang et al., 2003a; Walma et al., 2002). 
 
Some PDZ domain-ligand interactions, however, do not fall into any 
established system of classification. Some PDZ domains, for example, are 
known to bind to sequences lacking carboxylate termini; syntrophin is 
known to interact with an internal sequence in nNOS, an interaction that is 
dependent on its unique β-finger conformation (Hillier et al., 1999). 
Similarly, the interaction of PDZ domains with circular peptides is also 
conformationally dependent (Gee et al., 1998). Other ‘unclassifiable’ PDZ 
domain interactions exist. Both PDZ7 from GRIP and the alternatively 
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spliced PDZ2 from PTP-BL possess closed canonical binding pockets (Feng 
et al., 2002; Walma et al., 2004; Chapter 3; Kachel et al., 2003), leaving 
open the possibility of alternate interactions, such as those proposed with 
phosopholipids (Zimmermann et al., 2002; Kachel et al., 2003), or with 
ligands on an alternate binding face (Feng et al., 2002). 
 
The precise structural interactions that govern the specificity of PDZ 
domains for ligands have not yet been clearly elucidated, thus leading to 
situations that current classification systems cannot account for. Accounting 
for these exceptions in an all-inclusive classification system would 
strengthen our understanding of the specificity requirements of PDZ 
domains. We chose the PDZ2 of PTP-BL as a model system to assess the 
promiscuity of interactions displayed by PDZ domains. PDZ2 binds several 
ligands with varying affinities, including a traditional class 1 ligand from 
APC (Erdmann et al., 2000) and class 3 ligand from the protein RIL (Walma 
et al., 2002; Chapter 2). This binding diversity renders PDZ2 an interesting 
model for examining the factors that affect the specificity of PDZ domains. 
 
PTP-BL is a broadly expressed protein tyrosine phosphatase that 
participates in many signaling pathways (see Chapter 1for further details). 
The precise intracellular role of PTP-BL remains to be clarified, but the 
nature of the proteins with which it associates points towards function in 
microfilament dynamics, cell division and programmed cell death (Erdmann 
et al., 2000). For example, the LIM domain-containing protein RIL was 
recently disclosed as a regulator of actin stress fiber stability (Vallenius et 
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al., 2004). Mutations in the tumor suppressor protein APC  have been linked 
to human familial and sporadic colon cancer (van Es et al., 2001). 
6.2 Results 
PDZ2-APC Complex 
We report the solution structure of PDZ2 in complex with the final ten C-
terminal residues of the APC protein, determined using heteronuclear 
multidimensional NMR spectroscopy (see Figure 6.2). The structural 
statistics for the NMR ensemble are listed in Table 6.1. The structure is well 
defined with RMS Z scores close to 1 and 75 % of the residues in the most 
favored region of the Ramachandran plot. 
 
The structural ensemble of the PDZ2-APC complex differs from that of the 
native PDZ2 structure (PDB code 1gm1; Walma et al., 2002; Chapter 2) 
with several binding-dependent changes. The residues in the binding pocket 
are generally much more ordered when compared to the free domain, 
indicating that the bound ligand lowers their conformational mobility. When 
the two domains are structurally aligned, we see that the orientation of the 
αB helix changes ~15° relative to the βB strand, from 23°± 2.8° in the free 
domain to 38° ± 2.4° in the complex (Figure 6.2C). A similar change in the 
relative orientation of the βB strand and αB helix was previously also 
observed in the alternatively spliced variant of the PDZ2 domain, PDZ2as 
(Walma et al., 2004; Chapter 3). Likewise, we see in Figure 6.2D that the 
angles of the two αB helices are similar. 
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Specific interactions orient the APC ligand in the peptide binding groove, as 
shown in Figure 6.2B. The changes in chemical shifts upon complex 
formation, displayed in Figure 6.3, are in agreement with the observed 
interactions. The conformation of the carboxylate-binding loop enables the 
amides of Leu 25, Gly 26 and Ile 27 to encircle and stabilize the charge of 
the carboxylate terminus of the ligand (Figure 6.2B). The decrease in their 
amide nitrogen shifts infers the formation of hydrogen bonding interactions 
and their altered Cα chemical shifts are consistent with conformational 
changes needed to accommodate the bound C-terminus of the APC peptide. 
Hydrogen bonding interactions between the P0 and P-2 amides of the ligand 
and the PDZ carbonyl groups of Ile 27 and Val 29 also secure the ligand to 
the βB strand. 
 
Several PDZ2 residues in the βC strand and the αB helix contact the APC 
ligand significantly and all of these interactions are conserved across the 
known PDZ-ligand complex structures (vide infra, Figures 6.2 and 6.3). The 
terminal P0 valine engages in hydrophobic contacts with Ile 27 and Leu 85.  
The P-3 valine packs into a second hydrophobic pocket on the βB/βC face 
formed by Val 29, Thr30 and Ala 46. These residues all display significant 
changes in their side chain chemical shifts. Lys 45 bends toward the ligand, 
also interacting with the P-3 valine of the ligand. The first residue of the αB 
helix, His 78, interacts via its Nε2 sidechain proton with the serine P-2 
residue. The shape of the L1 loop is not significantly altered by the presence 
of the ligand: the hydrophobic contacts between Val 37 and Tyr 43, which 
are evident in the free PDZ2 structure, still define the shape of the loop in 
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the complex. We do not detect specific L1 loop-ligand NOEs that were 
reported for the human orthologue (Kachel et al., 2003; Kozlov et al., 2002). 
L1 loop residues Val 33 and Asn 34 have altered conformations when 
compared to the native structure. These residues do not directly interact with 
the ligand, rather, Val 33 packs onto the βE-to-αB loop. Because these 
residues are spatially adjacent to His 78, whose orientation is significantly 
changed to interact with the Ser P-2 of APC ligand, we postulate that this 
interaction promotes the altered hydrophobic packing. The relaxation data 
also show that the flexibility of both the L1 loop and the βE-to-αB loop are 
altered in the complex (vide infra) when compared to the native form. 
 
Figure 6.2. (A). Stereo diagram of the PDZ2-APC complex. (B) The interactions of the 
APC ligand with specific residues on the PDZ2 domain are detailed in shades of gray: P0 
(darkest), P-1 (dark) P-2 (light) and P-3 (lightest). (C) The structure of the PDZ2-APC 
complex (dark gray) is structurally aligned with free PDZ2 (light gray) using MOLMOL 
(Koradi et al., 1996), showing a divergent αB helix angle (D) The structure  
of the PDZ2-APC complex (dark gray) structurally aligned with PDZ2as (light gray) using 
MOLMOL (Koradi et al., 1996), showing a similar αB helix angle. 
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Table 6.1. Structural statistics for the PDZ2-APC Complex. 
Structural Statistics PDZ2-APC complex 
Restraint Information 
Distance Restraints (intra/seq/med/long/inter) 
 
1470 (529/323/166/378/74) 
Hydrogen Bonding Restraints 28 
Dihedral angle restraints (phi/psi/chi) 154 (69/72/13) 
Average RMS deviation from experimental restraints 
distance restraints (Å) 
dihedral angle restraints (°) 
0.046 ± 0.002 
0.384 ± 0.095 
Pairwise Cartesian RMS deviation (Å) 
Global backbone heavy atoms 
Global all heavy atoms 
 
0.77 ± 0.14 
1.63 ± 0.22 
Ramachandran quality parameters (%)a 
Residues in favored and allowed regions 
Residues in disallowed regions 
 
95.8 (75 and 20.8) 
1.3 
Average RMS deviation from current reliable structures (RMS Z-scores, null 
deviation = 1)a 
Bond lengths 
Bond angles 
Omega Angle Restraints 
Side chain Planarity 
Improper dihedral distribution 
Inside/Outside distribution 
1.002 
1.218 
1.504  
1.168 
0.891 
1.075 
Average deviation from current reliable structures (Z-scores, null deviation = 0)a 
2nd generation packing quality 
Ramachandran plot appearance 
Chi-1/chi-2 rotamer normality 
Backbone conformation 
-4.376 
-3.081 
-2.507 
-2.645 
a Values based on WHAT-CHECK reports, which are available for every structure 
deposited in the Protein Data Bank. 
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Figure 6.3. Changes in PDZ2 upon ligand binding. 
(A) Changes in chemical shift upon ligand binding as a function of residue number. The 
change in chemical shifts (complexed – free domain) for the PDZ2-APC complex (black, 
solid line) and PDZ2-RIL complex (gray, dashed line).  
(B) Changes in dynamics in PDZ2 upon ligand binding as a function of residue number. 
The change in Modelfree-derived relaxation parameters (complexed – free domain) for the 
PDZ2-APC (solid black line) and PDZ2-RIL complexes (dashed gray line). Secondary 
structural elements are displayed at top of both panels. Transparent gray bars indicate the 
PDZ2 residues that contact ligand residues, according to Figure 6.2. The L1 loop is 
represented by the lighter gray bar. 
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Dynamics 
To further characterize the effect of ligand binding on the PDZ2 domain, we 
measured 15N relaxation data for the PDZ2-APC and PDZ2-RIL complexes 
and calculated the order parameters (S2), internal correlation times (τe) and 
chemical exchange contributions (Rex) for each residue and compared these 
to the native PDZ2 domain by calculating their differences (Figure 6.3B). 
Overall, the entire PDZ2 domain becomes slightly more flexible upon 
ligand binding, as indicated by decreased S2 values for the majority of 
residues across the domain. However, several residues in the PDZ2-APC 
complex that interact specifically with the ligand show higher order 
parameters, in particular, several residues in the βB strand, as well as His 77 
and Leu 85 become more rigid. The most dramatic differences are observed 
for the residues in the L1 loop, with large changes to the S2, τe and Rex 
contributions. 
 
Comparison with the RIL Ligand 
By completely assigning the PDZ2 resonances while in complex to either 
the APC or RIL ligands, and comparing their chemical shifts and dynamics 
parameters with the native form, we obtained insight into the structural 
determinants that govern their binding (Figure 6.3). As expected, most of 
the residues in PDZ2 domain appear to interact very similarly with RIL and 
APC, indicating that PDZ2 binds the C-terminus of RIL in a fashion similar 
to its interaction with APC. However, both ligands bind to PDZ2 with 
different affinities, with dissociation constants of 190 and 1400 µM for the 
APC and RIL ligands, respectively (Walma et al., 2004; Chapter 4). 
Correspondingly, the effects of the RIL interaction with the βB strand of 
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PDZ2 are less prominent in several places, reflecting its lower affinity for 
the RIL ligand. In addition, the RIL ligand does not appear to induce the 
large effects on the L1 loop that were so obvious in the PDZ2-APC 
complex, suggesting that conformational changes in the L1 loop are not 
essential for the ligand binding ability of PDZ2, such as has been previously 
suggested (Kozlov et al., 2002). These data emphasize the importance of the 
P0 ligand identity on ligand binding and also the influence of the binding 
pocket shape (Walma et al., 2004; Chapter 3). 
 
Some effects induced by the RIL ligand are significantly larger when 
compared to the effects induced by the APC ligand. For example, Ile 48 
shows more prominent chemical shift changes for the RIL ligand when 
compared to APC (Figure 6.3). Chemical shift data indicate that His 78 also 
interacts differently with both peptides. His 78 enters a doubly protonated 
state in the RIL complex, whilst in the APC complex, His 78 is 
deprotonated on the Nε2 nitrogen, (refer to experimental procedures for 
details). The structure of the PDZ2-APC complex shows that the APC 
ligand interacts with the Nε2 of His 78 by hydrogen bonding to the sidechain 
oxygen of the Thr P-2 residue. In contrast, we speculate that the RIL ligand, 
which contains a Glu at the P-2 position, donates a proton to the His 78 N
δ1, 
without affecting the protonation of Nε2 nitrogen. We postulate that these 
differences are partly responsible for the dissimilar binding affinities. 
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Analysis of PDZ-ligand complexes 
To date, more than 13 PDZ-ligand complexes have been characterized and 
deposited in the protein data bank (Birrane et al., 2003; Skelton et al., 2003; 
Cheyette et al., 2002; Daniels et al., 1998; Doyle et al., 1996; Hillier et al., 
1999; Im et al., 2003; Kang et al., 2003b; Karthikeyan et al., 2001a; 
Karthikeyan et al., 2001b; Kimple et al., 2001; Kozlov et al., 2002; Schultz 
et al., 1998a; Tochio et al., 1999). We made a detailed examination of a 
subset of eight high quality, non-redundant structures to quantify the types 
of interactions that govern PDZ-C-terminal ligand association (listed in 
Table 6.2), and extensively compared the solvent accessibility and 
structurally equivalent contacts in each PDZ-ligand complex. 
 
Table 6.2. Unique PDZ-ligand complexes used for structural analysis. 
PDB code PDZ domain Ligand Ligand 
Sequence 
Traditional 
Class 
1oby PDZ2 Syntenin Syndecan-4 TNEFYA 2 
1obx PDZ2 Syntenin IL5Rα ETLEDSVF 1 
1ihj N-term INAD Norpa GKTEFCA 2 
1n7f PDZ6 GRIP Liprin ATVNTYSC 1 
1mfg PDZ1 Erbin Erbb2 receptor EYLGLDVPV 2 
1l6o PDZ1 Disheveled Dapper 1, pr1 SLKLMTTV 1 
1kwa PDZ1 CASK CASK PSYREFEF 2 
1be9 PDZ3 PSD-95 Cript  KQTSV 1 
 
The structural alignment of the eight sequences, annotated with a consensus 
sequence, is displayed in Figure 6.4A, together with a plot of the cumulative 
residue-specific contact surface areas. Of the approximately 90 residues that 
constitute PDZ domains, only 23 show any direct contacts with C-terminal 
ligands. The majority of these contacts involve the carboxylate-binding loop 
(labeled C), the βB strand and the inner surface of the αB helix, and most of 
these residues also show high levels of sequence conservation. For example, 
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the carboxylate-binding loop contains two hydrophobic residues 
surrounding a highly conserved glycine. This glycine redirects the backbone 
to correctly position the amides that coordinate the carboxylate group of the 
ligand. Residues that contact the side chain of the ligand P0 residue are 
uniformly conserved as hydrophobic or aliphatic residues. The highly 
conserved aliphatic residue at the third position of the βB strand (termed 
position βB3, e.g. Val 29 in PDZ2) displays the highest cumulative 
interaction with the ligands. Three residues in the βC strand also display 
contacts, and these residues are conserved as turn-like/polar and 
hydrophobic residues. In addition, we observed three L1 loop residues 
which contact ligand residues. These loops vary structurally between PDZ 
domains and display poor sequence conservation. 
  
Figure 6.4B displays the relative solvent accessibility of individual ligand 
residues while in complex with their respective PDZ domains. The terminal 
ligand residue P0 is consistently buried, indicating its importance in PDZ 
domain recognition. The data displayed in Figure 6.4B also suggests that 
PDZ-ligand interactions can be grouped according to the solvent 
accessibility of their P-1 residues. We decided to further analyze the 
complexes based on this solvent accessibility, grouping PDZ-ligand 
complexes with highly buried P-1 residues (>80%) into one group and those 
with less buried P-1 residues in a second group, defined as <75%, and 
terming these type P1 and type P2 interactions, respectively. 
 
124 Chapter 6 
 
Figure 6.4B illustrated a second feature discriminating the P1 and P2 
groups. Beyond the P-2 ligand residue, the interactions of type P1 ligands 
tend to decrease, while type P2 ligands tend to regain contact with the PDZ 
Figure 6.4. Contacts and solvent accessibility of PDZ-Ligand complexes. 
(A) The total ligand surface contact area (Å2) of structurally aligned PDZ domain 
residues vs. the consensus PDZ sequence, determined by the program SMART: 
hydrophobic (A,C,F,G,H,I,K,L,M,R,T,V,W,Y), polar (C,D,E,H,K,N,Q,R,S,T), turn-like 
(A,C,D,E,G,H,K,N,Q,R,S,T), aliphatic (I,L,V), tiny u (A,G,S), small 
(A,C,D,G,N,P,S,T,V), charged (D,E,H,K,R), negative – (D,E), positive + (H,K,R). 
Important structures are numbered by residue and identified by labels: βB, βC and αB 
refer to their secondary structural elements, T (βA-βB turn), C (carboxylate-binding 
loop), L1 (β2-β3 loop). The residue C4 is identical to residue βB1. 
(B) The fraction of buried surface area (Å2) for individual ligand residues while in 
complex with their respective PDZ domains. The ligands are grouped into two 
categories, type P1 (gray) and type P2 (black), depending on the solvent accessibility of 
the P-1 residue (see text for details). 
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domain. In addition, these differences do not correlate with the traditional 
ligand classification system, as they are spread equally across both newly 
proposed binding types (see Table 6.3). 
 
We further quantified the contacts between specific PDZ and ligand residues 
to elucidate the interactions that determine the specificity of each type. The 
results of this analysis are shown in Figure 6.5, with type P1 and P2 
complexes again depicted in gray and black, respectively. Most of the 
contacts with P0 involve highly conserved hydrophobic residues in the 
carboxylate-binding loop and αB helix, in particular C2, C4, αB5 and αB8 
(see also Figure 6.4A). Other residues, such as T1 (a conserved polar 
residue), also show minor contacts. This residue, located in the βA-to-βB 
turn, has been reported to interact with the ligand carboxylate via a 
structured water molecule, stabilizing its charge (Doyle et al., 1996). The 
contacts observed for both interaction categories are similar, although P1 
ligands tend to contact the αB helix more. 
 
The P-1 residue is also involved in important hydrophobic contacts with 
PDZ domain residues. In P1 ligands, the P-1 residue bends toward the βB 
and βC strand while in P2 ligands, the P-1 residue faces out of the binding 
pocket toward the αB helix. These results correlate with the solvent 
accessibility results displayed in Figure 6.4B. 
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Figure 6.5. The contact surface area (Å2) per ligand residue for 8 unique PDZ-ligand 
complexes, summarized for both P1-type ligands (dashed gray) and P2-type ligands (solid 
dark). At top, the secondary structural elements are displayed. The equivalent numbering 
for the PDZ2 of PTP-BL is listed at the base. Refer to Figure 6.2 for labeling details. 
 
Type P2 interactors display more specific interactions with the P-2 residue 
when compared to type P1 interactors. Analysis of the structures indicates 
that the hydrophobic portions of the type P2-P-2 residues face upward 
toward αB9 in the αB helix, whereas type P1 ligands are directed toward 
αB1. The interactions involving P-3 residues are much less evident when 
compared to previous ligand residues. Type P1 P-3 residues most 
prominently interact with conserved residues at the base of the βB strand, 
such as βB2 and βB4, whereas in type P2 complexes, P-3 interacts with a 
multitude of residues in the βB and βC strands and αB helix. The P-4 
interactions are even more erratic. P1 ligands interact significantly with βB2 
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and βB4, while P2 ligands interact most significantly with the αB helix, in 
particular αB1, the base of the βB strand, and non-structurally conserved 
loop residues. The P-5 residues do not consistently interact with specific 
PDZ residues, as indicated by the large error bars for the P1 interactions. 
6.3 Discussion 
PDZ2-APC complex 
The APC ligand in complex with the PDZ2 domain forms a well-determined 
structural ensemble with good quality parameters (Table 6.1). The 
carboxylate-binding loop coordinates the free carboxyl terminus of the APC 
ligand, and specific residues in the βB strand and αB helix participate in 
hydrophobic contacts to the terminal valine. These become more rigid in the 
complex, and this effect is particularly noticeable with His 77, Leu 85 and 
residues in the βB strand (Figure 6.3B). Similarly, an increase in rigidity in 
the binding pocket due to ligand binding has also been observed for the 
human orthologue of the PDZ2 domain (Fuentes et al., 2004). Several 
hydrogen bonding interactions pair the ligand with the βB, giving it an 
extended conformation, in accordance with the deshielded amide protons 
along the βB strand. The P-3 valine residue folds over onto the βB-βC sheet, 
engaging in several NOE contacts with a hydrophobic pocket on the PDZ2 
domain (Figure 6.2B). 
 
The orientation of the αB helix relative to the βB strand also changes upon 
ligand binding, turning outward and downward with an angle difference of 
~15° (Figure 6.2C). The side chain of His 78 (αB1) is reoriented, donating a 
proton to the side chain of Thr P-2 of the APC peptide in a hydrogen 
128 Chapter 6 
bonding interaction. The reorientation of the αB helix as noted in the PDZ2-
APC complex was previously observed in the alternative splice variant of 
the PDZ2 domain, PDZ2as (Walma et al., 2004; Chapter 3). In both cases, 
the change in helix orientation can be attributed to differential hydrophobic 
packing at the base of the binding pocket (Figures 6.2C and 6.2D). In 
PDZ2as, the last hydrophobic residue of the βB strand, Val 31 of the 
insertion, packs against the βE-to-αB loop while in the PDZ2-APC complex 
the first hydrophobic residues of the L1 loop (Val 33/Asn 34) lose this 
ability to pack. The altered conformation of the βE-to-αB loop in the PDZ2-
APC complex is promoted by the interaction of the αB1 histidine residue 
with the ligand. It is clear from these results that the orientation of the αB 
helix in PDZ domains is a critical factor both influencing and being 
influenced by the binding of ligands. In addition the helix angle is strongly 
affected by the positioning of the βE-to-αB loop, which in turn is influenced 
by hydrophobic packing and interactions of the αB1 residue. Structural 
comparisons of the native PDZ2 with either the PDZ2-APC complex or 
PDZ2as, as summarized by pairwise RMS deviation (Figure 6.6), show that 
ligand binding and splice insertion structurally affect similar regions, most 
notably, the βA-to-βB and βE-to-αB turns, the L1 loop and the αB helix. 
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Figure 6.6. Pairwise backbone RMSD (Å) of the free PDZ2 domain (PDB code 1gm1) with 
either the PDZ2-APC complex (PDB code 1vj6), or the PDZ2as domain (PDB code 1ozi). 
The secondary structure of the free PDZ2 domain is displayed at the top. 
 
Comparison with RIL 
PDZ2 of PTP-BL binds ligands that belong to different classes, examples of 
these being the APC ligand (class 1) and RIL ligand (class 3). Using the 
PDZ2-APC complex, the chemical shift differences following complex 
formation and the changes in dynamical data, we assessed the factors that 
define the ligand specificities of PDZ domains. 
 
The interactions of APC and RIL exhibit many similarities. The pattern of 
hydrogen bonding along the carboxylate-binding loop and βB strand are 
analogous. The affinity of these ligands is enhanced by two distinct 
hydrophobic pockets that bind the P0 and P-3 valines from both ligands. Both 
ligands do not directly contact the L1 loop. The affinity for the RIL ligand is 
less than that for the APC ligand, which can be attributed to the different 
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interactions of its P-1 and P-2 residues. Presumably, the Leu P-1 residue of 
RIL more favorably interacts with Ile 48 (position βC7) because of their 
mutual hydrophobic nature, whereas the APC ligand is not capable of this 
interaction. The APC Thr P-2 residue deprotonates His 78, discouraging the 
hydrophobic packing of the L1 loop against the βE-to-αB loop, and thereby 
increasing the mobility of the L1 loop at the base of the binding pocket. 
Conversely, the Glu P-2 of RIL appears to induce a doubly-protonated 
histidine tautomer, leaving the conformation of the L1 loop unaltered with 
respect to the native protein. These patterns of interactions reveal that PDZ2 
interacts differently with the APC and RIL ligands, and these differences are 
responsible for their different binding affinities.  
 
Current classification techniques of PDZ domains are unable to predict the 
multi-class binding characteristics of PDZ domains and their differences in 
affinities. Based on structural data for eight PDZ-ligand complexes, we used 
the relative solvent accessibility of the P-1 ligand residue to define two 
distinct groups of PDZ-ligand interactions, denoted as type P1 and P2 
(Figure 6.4). 
 
The P1 and P2 type interactions can be rationalized by closely examining 
the sequence identities of the PDZ and ligand pairs, as listed in Table 6.3. 
We observe that P1 ligands which possess hydrophobic P-1 residues interact 
with likewise hydrophobic residues in the βB and βC strands. Similarly, a  
P-1 glutamic acid in the CASK complex favorably interacts with two 
arginine residues at the βC5 and βC9 positions. Other residues contribute to 
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these interactions (e.g. C1 and αB9) more sporadically. A cysteine at the P-1 
position covalently binds the βB2 cysteine in the INAD complex. 
 
Importance of the P-1 residue 
Other reports have also suggested the importance of the P-1 residue, and 
their data are summarized at the bottom half of Table 6.3. For instance, the 
Erbin PDZ domain possesses a preference for ligands with tryptophan at P-1 
position, binding ligands with the consensus sequence -(A/E)TWV*(Laura 
et al., 2002; Skelton et al., 2003). This specificity is promoted because the 
Trp packs into a pocket formed by the βB2, βC5 and βC7 residues. The 
sidechain nitrogens of the Trp are stabilized by ionic interactions with Arg 
Table 6.3. Categorized summary of PDZ-ligand complexes.  
PDZ domain C1 βB2 βC5 βC7 αB9 Ligand Sequence 
Traditional 
Class 
Type 
PDZ2 syntenin His Ile Ser Val Ser TNEFYA 2 P1 
PDZ2 syntenin His Ile Ser Val Ser ETLEDSVF 1 P1 
N-term INAD Ser Cys Gly Ile Lys GKTEFCA 2 P1 
PDZ CASK Pro Thr Arg Met Arg PSYREFEF 2 P1 
PDZ6 GRIP1 Pro Thr Ser Thr Gln ATVNTYSC 1 P2 
PDZ Erbin Glu Ser Arg Gln Lys EYLGLDVPV 2 P2 
Dishevelleda Phe Ser Gly Ile Arg SLKLMTTV 1 P2 
PDZ3 PSD95 Gly Asn Phe Leu Lys KQTSV 1 P2 
PDZ domain C1 βB2 βC5 βC7 αB9 Ligand Sequence 
Traditional 
Class 
Type 
PDZ2 PTP-BLb Ser Ser Ala Ile Arg VRHSGSYLVTSV 1 P2 
PDZ2 PTP-BLb Ser Ser Ala Ile Arg VAVYPNAKVELV 3 P1 
PDZ Erbin Glu Ser Arg Gln Lys A/E-TWV 2 P1 
PDZ2 MAGI-3 Gly Arg Ala Ile Thr QITWV 2 P1 
PDZ1 NHERF Gly Leu Arg Glu Arg QDTRL 2 P1 
The upper panel lists PDZ complexes that were used in the structural alignment analysis. The 
lower panel lists additional PDZ complexes, or interaction data derived from biological 
experiments. The P-1 residues, as well as the PDZ ligand residues they contact, are bolded. 
The ligand sequences refer to ligands previously reported in Table 6.2. 
PDB codes for protein domains as reported: PDZ2 syntenin (1oby), PDZ2 syntenin (1obx), 
N-term INAD (1ihj), PDZ CASK (1kwa), PDZ6 GRIP1 (1n7f), PDZ Erbin (1mfg), 
Dishevelled (1l6o), PDZ3 PSD95 (1be9) 
a P-1 residue also contacts a selenomethionine, a molecular replacement artifact. 
b This work 
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and Gln, thus rendering it a P1 interaction in our new categorization system 
(Table 6.3). The importance of P-1 residue is also demonstrated by the 
interaction of the second PDZ domain of MAGI-3 with the PTEN  
C-terminus. The methylation of its P-1 Trp side chain nitrogen was found to 
dramatically affect its binding (Novak et al., 2002). The ionic character of 
the βB2 and hydrophobic character of βC5 and βC7 clearly explain why this 
interaction is also a P1 type. In another example, PDZ1 from NHERF also 
possesses an affinity for ligands with arginine at the P-1 position, this 
specificity being conferred by an Asn and Glu at the C2 and βC7 positions, 
the interaction of C2 is promoted by the unusual shape of the carboxylate 
loop (Karthikeyan et al., 2001b). 
 
A study of the binding patterns of the second PDZ domain of syntenin 
concluded that the affinity for the ligands was determined by a combination 
of binding sites: the IL5Rα ligand (sequence –SVF*) was bound primarily 
by hydrophobic interactions involving the P0 and P-1 whereas for the 
syndecan ligand (sequence -FYA*) the P-1 and P-2 residues were involved 
(Kang et al., 2003a). Both of these ligands contain large hydrophobic P-1 
residues, confirming their inclusion as a P1-type interaction. Surprisingly, 
the P0 residue of each ligand is highly buried (Figure 6.4B), despite the 
considerably different sizes of Phe and Ala. The affinity of IL5Rα is slightly 
higher than that of syndecan, underlining the importance of the hydrophobic 
contacts of the P0 residue. 
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Several studies have shown that very specific point mutations can alter the 
ligand-binding specificities of PDZ domains. For instance, the AF-6 PDZ 
domain required at most 1 or 2 point mutations to interact with a ligand, in 
positions exclusively limited to C1, βB2, βB4, αB1, and αB2 (Schneider et 
al., 1999). These mutations all involved inserting residues with bulkier and 
more hydrophobic side chains to gain interactions with similarly 
hydrophobic residues at ligand P-1, P-2 and P-3 positions. Another study used 
point mutations to force PDZ3 from PSD95 to selectively bind ligands 
containing either hydrophobic or polar residues in their P-1 and P-3 positions 
(Reina et al., 2002). This specificity was achieved by specific mutations of 
the βB2, βB4, βC4, βC5, βC7, and αB9 positions. From Figure 6.5, it is 
clear that these residues uniquely contact the P-1 and P-3 residues and are 
therefore reasonable targets for mutation. Thirdly, the specificity of the 
nNOS PDZ domain was changed from -DxV* to -TxV* sequences by 
mutating only the positions αB1 and αB2 from Tyr to His and Asp to Glu, 
respectively (Stricker et al., 1997), thus confirming the importance of 
interactions between the αB helix and the P-2 ligand position. This result 
also raises the possibility that PDZ2 of PTP-BL could also be altered by the 
reverse H78Y mutation, to have higher affinities for ExV* sequences over 
SxV* sequences. 
 
Explaining the ligand affinities for PDZ2 of PTP-BL 
We used our categorization scheme to explain the binding promiscuity and 
relative binding strengths of PDZ2 of PTP-BL. Several carboxyl-terminal 
ligands have been reported to bind to the PDZ2 domain and in particular, 
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two studies have been completed that relate relative ligand binding strengths 
(see Table 6.4). Because PDZ2 contains hydrophobic residues in positions 
that interact with P-1 ligand residues, we propose that ligands with large 
hydrophobic P-1 residues participate in more P-1-specific contacts and hence 
display fewer overall contacts with the PDZ domain, resulting in lower 
binding affinities. Correspondingly, we observe that in two respective 
studies, hFas and RIL, both classified as P1 interactors, have lower affinities 
compared to the P2-type ligands. Our scheme also predicts that ligands with 
both small P-1 and hydrophilic P-2 residues, will bind more strongly to the 
PDZ2 domain, and indeed, the binding constants for these ligands are the 
highest. 
 
Table 6.4. Summary of two studies comparing the interactions of PDZ2 of PTP-BL with 
diverse ligands. 
Method Ligand Ligand Sequence Affinity (Kd) Type 
NMR RIL PNAKVELV 1400 µMa P1 
NMR p75NTR SESTATSPV 300 µMb P2 
NMR APC KRHSGSYLVTSV 190 µMb P2 
Yeast two hybrid human FAS DSENSNFRNEIQSLV 200-500 µMa, 30 µMc P1 
Yeast two hybrid TRIP-6 SATVTTDC 10x stronger than hFasd P2 
a (Walma et al., 2002; Chapter 2) 
b (Chapter 4) 
c (Ekiel et al., 1998) 
d (Murthy et al., 1999) 
 
In our categorization system, the PDZ2-APC complex is classified as a  
P2-type interaction. Indeed, the small polar character of its Ser P-1 residue is 
not capable of hydrophobic contacts with the βC5 and βC7 residues, giving 
the P-2 Thr the conformational flexibility to interact with the αB1 His, while 
the side chain methyls of the P-3 Val interact with a secondary hydrophobic 
pocket on the βB-βC sheet. The combined effect of these three interactions 
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results in the highest ligand affinities, as has been observed and are reported 
in Table 6.4. The presence of hydrophobic P-1 residues in RIL and the 
human Fas C-terminal ligands promotes P1 type interactions and negatively 
affects their affinity for the PDZ2 domain. For RIL, chemical shift data 
(Figure 6.3) support these differential binding modes, displaying 
pronounced differences between the APC and RIL complexes for Ile 48 at 
the βC7 position. 
 
We also compared our results to those deposited for the orthologous human 
PDZ2 domain with the RA-GEF-2 ligand (-FADSEADENEQVASAV*), an 
interaction for which a Kd of 10 µM was reported (Kozlov et al., 2002). 
Based on our model, this interaction is postulated to be a type P2 
interaction. Similar to our results for the PDZ2-APC complex, most of the 
NOEs connecting RA-GEF-2 ligand to the PDZ2 domain involve contacts 
with hydrophobic P0 (valine), the P-2 (serine) and P-3 (alanine) residues, with 
7, 13 and 8 out of a total of 44 intermolecular contacts for these reported, 
respectively. As with our complex, no specific interactions were reported 
with the L1 loop. 
6.4 Conclusions 
PDZ2 of PTP-BL possesses an affinity for a variety ligands, two of which 
were studied in detail, a traditional class 1 sequence from the tumor 
suppressor protein APC and a traditional class 3 sequence from the RIL 
protein (Erdmann et al., 2000; Walma et al., 2002; Chapter 2). The RIL and 
APC ligands are representative examples demonstrating a newly proposed 
PDZ-ligand interaction categorization system. Structural data clearly show 
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the P-1 ligand residue in PDZ domain interactions significantly influences 
the interaction characteristics of subsequent residues. PDZ2 binds RIL via a 
type P1 mechanism and APC via a type P2 mechanism, thus resulting in 
their different binding affinities. These data show that it is too simple to 
classify PDZ-ligand interactions based on sequence of either the PDZ 
domain or the ligand alone and that both interaction partners must be 
considered to make an accurate prediction. 
 
Our structure-based system organizes PDZ-ligand complexes in a new way. 
Firstly, we categorize ligands with >80% buried P-1 positions as P1 
interactors. This situation has a tendency to disrupt further N-terminal 
ligand interactions with the PDZ domain (Figure 6.4B) A second P2-type 
category has more exposed P-1 residues when compared to their P-2 residues 
(<75 % buried). The limited interactions of P-1 allow the P-2 residues of 
these ligands participate in well-defined interactions with the PDZ domain 
(Figures 6.4B). The P-1 residues of type P1 ligands tend to be hydrophobic 
(Tyr, Val) or covalently bound to the PDZ domain (as observed in the 
cysteine bridge of the protein INAD), while those of type P2 interactions 
tend to be small and polar (Ser, Thr, Ser), or unusually shaped, such as 
proline (Table 6.4).  
 
The PDZ domain residues that contact ligands most extensively are located 
in the βB strand; however, these residues do not appear to be involved in 
selectivity because these contacts are consistent through all categories of 
PDZ interactions. Instead, selectivity is determined by those PDZ residues 
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which differentially contact ligands. Therefore, we additionally propose to 
define the interaction type of a given PDZ-ligand interaction by grouping 
PDZ domains according to the identity of their βB2, βC5, and βC7 residues, 
residues which universally interact with the P-1 ligand position (Table 6.3). 
For example, in PDZ2, these residues are Ser, Ala and Val, respectively, and 
are predicted to preferentially interact with hydrophobic P-1 ligand residues, 
thus clarifying why the PDZ2-RIL interaction is a P1 type interaction and 
why the PDZ2-APC interaction is a P2 type. 
 
We chose to study the binding patterns of PDZ domains on the basis of the 
fraction of buried surface because this quantity directly results from a 
multitude of processes that occur during the process of ligand binding, such 
as hydrogen bonding interactions, hydrophobic packing and mobility, and 
therefore is expected to correlate with binding affinity. Our results show that 
this simplistic manner of examining complexes is capable of powerful 
predictions. Further, our results support the recently proposed combinatorial 
model of PDZ domain interactions (Kang et al., 2003a). We extend this 
model to include the final four ligand residues, encompassing P0 to P-3. Our 
new model bases its categorization on structural data and our conclusions 
provide a sound basis for the predictive classification of PDZ domains from 
sequence information. Our system also accounts for the promiscuity and 
affinity of PDZ ligands within a defined range of selectivity. 
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6.5 Experimental Procedures 
Protein Expression 
The production of the PDZ2 domain was described previously (Walma et 
al., 2002; Chapter 2). Briefly, the vector containing the PDZ2 domain, 
comprising residues 1351 to 1444 of the protein PTP-BL was expressed 
with an N-terminal His-tag using a modified pET28a plasmid in Escherichia 
coli BL21 (DE3) cells. Uniformly 15N/13C-labelled PDZ2 samples were 
prepared using 15NH4Cl and 
13C-glucose as sole nitrogen and carbon 
sources. The soluble protein was purified using both a Ni2+-NTA agarose 
column (Qiagen) followed by an S-sepharose fast flow cation exchange 
column (Amersham Pharmacia). NMR samples contained ~1 mM dissolved 
protein in a buffer of 50 mM KH2PO4/K2HPO4 and 50 mM KCl, pH 6.8, 
H2O/D2O (95%/5%), using Complete protease inhibitor and trace NaN3 as 
preservative. 
 
Peptide Interactions 
The peptides, ordered from Ansynth Service BV (Roosendaal), contained an 
N-terminal biotin group and a C-terminal carboxyl group. The peptide 
sequences corresponded to the final twelve C-terminal residues of RIL and 
the APC C-terminal peptide corresponded to the final ten residues. The 
peptides were titrated to completion (>3.2 equivalents) in individual 1 mM 
15N/13C protein samples. The differences in backbone HN and N chemical 
shifts were monitored with 15N-HSQC spectra recorded at 600 MHz and 
25°C. The vectors of the (initial – final) HN and N frequencies (Hz) vs. the 
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relative concentrations were fit using a least squares procedure to determine 
dissociation constants for the peptides.  
 
NMR spectroscopy 
All NMR experiments were carried out at 25°C on Varian Unity Inova 
spectrometers operating at 600 and 800 MHz. The sequential assignment 
was completed using HNCA, HAHBCONH, HNCOCO, (H)CCH TOCSY 
spectra. The characteristic NOE patterns allowed the secondary structural 
elements to be determined. Interatomic contacts with the APC peptide were 
assigned from alignment with other complexes, proton chemical shifts and 
comparison with the free PDZ2 NOESY spectra. These were supported by 
the CSI of the Hα protons, and by comparison to the structure of the free 
PDZ2 domain. The side chains of the histidine residues were assigned by 
firstly correlating the Cβ frequency with Cδ2/Hδ3 and secondly correlating 
the Cδ2/Hδ2 with Nε2, and Nε2 with Cε1/Hε1 using constant time/sensitivity 
enhanced experiments. The distance restraints for the PDZ2-APC complex 
were obtained from 3D 13C-NOESY-HSQC (100 ms mixing time) and  
15N NOESY-HSQC (80 ms mixing time). The relaxation data were recorded 
at 600 MHz (14.1T). We recorded T1, T1ρ and {
1H-15N}NOE experiments. 
Analysis of the data with the program Tensor2 (Dosset et al., 2000) showed 
that they were adequately described by an isotropic model. The S2, τe, and 
Rex values were derived using the program Modelfree 4.0 (Mandel et al., 
1995). 
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Structure Calculations 
Structures were calculated from experimental distance restraints (Table 6.1) 
in a Cartesian-space simulated annealing protocol in XPLOR version 3.851 
(Brunger, 1996). This yielded 91 out of 200 structures with no distance 
violations > 0.4 Å. These structures were then refined in water using a 
restrained molecular dynamics protocol under a CHARMM22 protocol 
(MacKerell et al., 1998; Spronk et al., 2002). Of these, the 35 structures 
with no distance violations > 0.4 Å were selected to form the final 
ensemble. Structural statistics were calculated using the programs 
PROCHECK-NMR (Laskowski et al., 1996) and WHAT-IF (Vriend, 1990). 
The hydrogen bonding restraints were determined from characteristic NOE 
patterns and H/D amide exchange data. The HN-O and the N-O hydrogen 
bonding distances were restrained from 1.2-2.2 Å and 2.2-3.2 Å, 
respectively. The structures and restraints have been deposited in the PDB 
(1vj6) and in the BMRB (6060), respectively. 
 
Structural Alignment Analysis 
The structural alignments were performed on each domain using WHATIF 
(Vriend, 1990), with a maximal displacement of 7 Å for each pair of Cα 
atoms and a global RMS limit of 4 Å. The sequence alignment was 
determined by the SMART analysis tool (Schultz et al., 1998b). The PDZ-
ligand contacts were quantified using the CSU server (Sobolev et al., 1999). 
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Summary 
PTP-BL is a large protein tyrosine phosphatase that is implicated to function 
in cellular processes as diverse as cytokinesis, actin-cytoskeletal 
rearrangement and apoptosis. The five PDZ domains of PTP-BL interact 
with other cellular proteins by binding to specific amino acid sequences of 
these target proteins. PDZ domains have been traditionally classified into 
two classes that consider the identity of the ultimate and antepenultimate C-
terminal ligand residues, termed P0 and P-2. Some PDZ domains display the 
ability to bind internal protein sequences. 
 
This thesis discusses the second PDZ domain in PTP-BL (PDZ2). It 
describes the structure and interactions of two naturally occurring variants 
of this domain. The first variant is the most common and has a length of 93 
residues. The second, termed PDZ2as, is five residues longer than the first. 
We report on interaction capabilities of these domains with several C-
termini of PDZ2 target proteins and the LIM domain of the protein RIL. The 
final chapter of this thesis reports on a new system for categorizing PDZ 
ligand interactions. 
 
The principal method used for investigating these properties was high 
resolution nuclear magnetic resonance, or NMR. Firstly, the structure for the 
PDZ2 domain was determined (Chapter 2). This structure showed that the 
PDZ2 domain adopts a fold very similar to other PDZ domains, consisting 
of two packed anti-parallel β-sheets flanked by two α-helices. Unique for 
PDZ2 is its long, flexible loop of 10 residues located between the βB-βC 
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strands, called the L1 loop. The interaction of the PDZ2 domain with the C-
terminal tails of the human and mouse Fas receptors and the RIL protein 
was also investigated. It was confirmed that PDZ2 binds the human Fas 
receptor C-terminus, but not that of the orthologous mouse Fas receptor. 
The PDZ2 domain was also found to bind the C-terminus of the RIL 
protein. 
 
Next, the structure of the longer alternatively-spliced version of PDZ2 is 
reported (PDZ2as) in Chapter 3. This splice variant contains five extra 
residues located near the lower portion of the binding pocket, which 
abrogate the affinity for C-terminal ligands. More specifically, the insert 
causes distinct structural and dynamical changes in PDZ2as: enlarging the 
L1 loop between the βB and βC strands, as well as changing the orientation 
of the αB helix. This gives the base of the binding pocket less flexibility to 
accommodate ligands and destabilizes the entire domain. 
 
We next investigated the binding properties of PDZ2. We report data for the 
interaction of PDZ2 with C-terminal ligands derived from the proteins APC, 
p75
NTR
,
 
and RIL in Chapter 4. The results demonstrate that the higher 
affinities for these carboxyl-terminal ligand interactions correlate with both 
stronger- and additional interactions of the ligand with PDZ2 residues.  
 
We also report the results for the interaction of PDZ2 with the LIM domain 
of the protein RIL in Chapter 5. Yeast two-hybrid experiments previously 
revealed that the PDZ2 bound specifically to the RIL-LIM domain, 
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independent of the C-terminal sequence. By comparing the interaction of the 
RIL C-terminal sequence with that of the LIM domain including the C-
terminus, we demonstrate that the structural characteristics of both 
interactions are very similar. Next, we also examined the interaction of the 
LIM domain alone (without the C-terminus) with the PDZ2 domain. Spectra 
recorded on these solutions exhibit no signs of interaction between the two 
solvated domains. Taken together, these results do not support the original 
hypothesis regarding the PDZ2 RIL-LIM interaction, but rather suggest that 
the RIL C-terminus does play a critical role in their association. 
 
Lastly, in order to more fully understand the promiscuous binding behavior 
of PDZ2, we solved the structure of the PDZ2 domain in complex with the 
C-terminus from the APC protein. We report this structure in Chapter 6. We 
contrasted the APC interaction to that of the RIL C-terminal ligand because 
these two C-termini bind to PDZ2 with different affinities. 
 
In addition, we completed a survey of PDZ-ligand interactions currently 
deposited in the Protein Data Bank. The analysis shows that the presence of 
strong interactions between the PDZ domain and the ligand residue at the 
penultimate (P-1) position correlates with lower ligand affinities. The 
analysis also shows that the final four C-terminal residues of the ligand must 
be considered in the PDZ binding motif. We propose a new structure-based 
categorization system that considers the interaction of the P-1 ligand residue 
with the second, fifth and seventh residues of the βC strand of the PDZ 
domain. The presence or absence of interactions with the penultimate 
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residue classify them as type P1 or type P2 interactions, respectively and 
explains their relative affinities. 
 
The work described in this thesis provides a clearer understanding of how 
the three-dimensional structure of a PDZ domain determines its interactions 
with C-terminal ligands. Seemingly innocuous changes to the size and shape 
of the PDZ binding pocket dramatically affect its ligand binding 
capabilities, while the specific identities of residues affect ligand affinities. 
The results presented in this thesis constitute an essential step in the 
predictive classification of PDZ domains from sequence information. 
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Samenvatting 
PTP-BL is een groot cellulair eiwit met fosfotyrosine activiteit. Het lijkt 
betrokken bij belangrijke cellulaire processen, zoals cytokinese, 
remodellering van het actine cytoskelet, en apoptose. De vijf PDZ domeinen 
van PTP-BL vormen complexen met andere cellulaire eiwitten door binding 
aan specifieke aminozuur-sequenties uit deze eitwitten. Traditioneel zijn 
PDZ domeinen ingedeeld in twee categorieën, op basis van de identiteit van 
het laatste en het twee na laatste C-terminale aminozuur van het ligand. 
Deze aminozuren worden de ultimate en antepenultimate aminozuren 
genoemd, of kortweg, P0 en P-2. Een derde, zeldzamere, soort interactie 
betreft de binding van PDZ domeinen aan interne sequenties in eiwitten. 
 
In dit proefschrift wordt het tweede PDZ domein (PDZ2) van PTP-BL 
onderzocht. Het beschrijft de structuur en interacties van twee varianten van 
dit eiwit-domein. De eerste en meest voorkomende variant, bestaat uit 93 
aminozuren. De tweede variant, het zogenaamde PDZ2as, is vijf aminozuren 
langer. De interactie-mogelijkheden van deze domeinen met verschillende 
C-termini van PDZ2 bindende eiwitten en met het LIM domein van het 
eiwit RIL worden bestudeerd. In het laatste hoofdstuk wordt een nieuw 
systeem gepresenteerd voor classificatie van PDZ domein-ligand interacties. 
 
Het onderzoek werd uitgevoerd met behulp van hoge resolutie kernspin 
resonantie (NMR). In hoofstuk 2 wordt de bepaling van de structuur van het 
PDZ2 domein beschreven. Deze structuur lijkt heel veel op die van andere 
PDZ domeinen, bestaande uit twee op elkaar gepakte anti-parallele β-sheets, 
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geflankeerd door twee α-helices. Een uniek aspect van PDZ2 is de flexibele 
L1 lus van tien aminozuren, die de β-strengen βB en βC met elkaar verbindt. 
Ook is de interactie van het PDZ2 domein met de C-termini van de humane 
en muis Fas receptoren en met de C-terminus van het RIL eiwit onderzocht. 
De resultaten bevestigden dat het PDZ2 domein bindt aan de Fas receptor 
van de mens, maar niet aan die van de muis. Het PDZ2 domein bindt ook de 
C-terminus van het eiwit RIL. 
 
In hoofdstuk 3 wordt de structuur van de tweede variant van PDZ2 
(PDZ2as) gerapporteerd.Vergeleken met het gewone PDZ2 eiwit heeft deze 
variant vijf aminozuren meer en deze bevinden zich onderin de bindings 
pocket. Deze verandering heeft tot gevolg dat dit eiwit niet de gebruikelijke 
liganden bindt. Verder werd gevonden dat de insertie van vijf extra 
aminozuren de structuur en dynamica van het PDZ2as verandert ten 
opzichte van PDZ2. De L1 lus die de β-strengen βB en βC verbindt is 
bijvoorbeeld langer. Ook de αB helix wordt langer en krijgt een andere 
orientatie ten opzichte van de βB streng dan in het PDZ2 eiwit. Dit leidt tot 
een vernauwing en verstarring van de bodem van de bindings pocket, 
waardoor binding van liganden wordt verhinderd, en resulteert tevens tot 
een algehele destabilisatie van het domein. 
 
Vervolgens hebben we de bindingseigenschappen van PDZ2 verder 
onderzocht. Eerst wordt de interactie van drie additionele liganden, te weten 
de C-termini van de eiwiten APC, RIL en NTR, geanalyseerd (hoofdstuk 4). 
De resultaten tonen aan dat een hogere affiniteit van deze C-terminale 
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peptide correleert met sterkere en additionele interacties van het betreffende 
ligand met PDZ2 residueën. 
 
In hoofstuk 5 worden de resultaten gerapporteerd voor de interactie tussen 
PDZ en het LIM domein uit het eiwit RIL. Zogenaamde “yeast two hybrid” 
experimenten hadden eerder gesuggereerd dat PDZ2 specifiek het RIL-LIM 
domein zou binden en dat deze interactie onafhankelijk was van 
aanwezigheid van de RIL C-terminale sequentie. Door de vergelijking van 
de interacties van de RIL C-terminus met die van het LIM domein inclusief 
de C-terminus, laten we zien dat beide interacties een grote mate van 
overeenkomst vertonen. Vervolgens zijn de interacties tussen PDZ2 en het 
LIM domein zonder de C-terminus bestudeerd. De spectra van oplossingen 
die deze beide eiwit domeinen bevatten, geven geen indicatie voor een 
interactie. De gezamenlijke resultaten bevestigen niet de originele hypothese 
betreffende de PDZ2 RIL-LIM interactie, maar geven aan dat de RIL C-
terminus essentieel is voor de PDZ2-RIL associatie. 
 
Teneinde de promiscue bindingseigenschappen van PDZ2 beter te 
begrijpen, is de struktuur van het complex gevormd door het PDZ2 eiwit en 
de C-terminale sequentie van het APC eiwit bepaald. Deze struktuur wordt 
in hoofdstuk 6 gerapporteerd. De interacties van het APC peptide met het 
PDZ2 domein worden vergeleken met die tussen het RIL C-terminale 
peptide en het PDZ2 domein in het licht van het verschil in 
bindingsaffiniteit dat deze twee C-termini etaleren.  
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Tevens wordt, op basis van de beschikbare gegevens in de PDB (Protein 
Data Bank), een analyse gemaakt van de interacties tussen verschillende 
PDZ domeinen en hun liganden. Deze analyse laat zien dat de aanwezigheid 
van sterke interacties tussen het PDZ domein en het ligand residue op de 
voorlaatste (P-1) positie, correleert met lagere bindings affiniteit. De analyse 
laat ook zien dat de vier laatste C-terminale residueën van het ligand 
gezamelijk het bindingsmotief bepalen. Wij doen een voorstel voor een 
nieuw, structuur-gebaseerd classificatie systeem, waarin de interacties van 
het P-1 ligand residue met het tweede, vijfde en zevende residue van de βC 
streng in het PDZ domein centraal staan. De aan- of afwezigheid van 
interacties van het voorlaatste residue, classificeert de interactie 
respectivelijk als type P1 of type P2, en verklaart de relative bindings 
affiniteit. 
 
Het werk beschreven in dit proefschrift geeft beter inzicht in de wijze 
waarop de structuur van een PDZ domein de interacties met C-terminale 
liganden bepaald. Ogenschijnlijke subtiele veranderingen in de grootte en 
vorm van de PDZ bindingspocket bepalen haar bindingsmogelijkheden, 
terwijl de identiteit van specifieke ligand residueën de affiniteit bepalen. De 
resultaten beschreven in dit proefschrift vormen een essentiele stap in de 
voorspellende classificatie van PDZ-domeinen op basis van sequentie 
informatie. 
Acknowledgements  165 
 
Acknowledgements 
The work described in this thesis was completed only with the support of 
many people. Firstly, I would like to thank my family who supported me 
during my thesis work: my parents who are, both advertently and 
inadvertently, leading me toward the meaning of life, my sister Esther, for 
our phone calls, and my brother Mathys, for sharing two vacations with me. 
 
Secondly, I would like to thank all the people who were essential for 
carrying out the research described in these pages. I would like to thank 
Geerten Vuister for his superb NMR abilities, Professor Hilbers who was 
the first to take a chance on me, a stranger in a small land, and finally 
Wiljan Hendriks, whose thoughtful comments helped the direction of my 
project. I also thank Jan Aelen, who managed to produce >200 mg of the 
double-labeled PDZ2 domain during the first six months I was here, enough 
protein to last for four years. I thank Jos Joordens for all the hardware and 
software support, Harrie Koster for his magical ability to fix things and 
Lieke van den Berk for her biological expertise. I would also like to thank 
the secretaries, Babs Klink, Maaike Noortman and later, Marian de With, all 
of whom have helped me to foray the murky waters of the Dutch 
government. 
 
My Ph.D. years would not be the same without my colleagues. From you, I 
learned the fine Dutch arts of coffee drinking, conversation, and real 
vacations. I thank my longest colleague, Hugo van Ingen, for his 
companionship and quirky humor, as well as Marlies Oostendorp, who 
166 Acknowledgements 
assisted with the measurements in Chapter 3. I also thank Sander Nabuurs 
and Chris Spronk for their tireless contributions in the areas of structure 
calculation and validation. 
 
Lastly I will always remember the kindness and the fragrant food of Ajith 
(and Sunitha), Chintaka (and Tilanka), and the care of my relatives (and 
their friends) who helped me while transitioning between cultures, 
especially Victoria, Fokje, Oom Cees, Tante Co, Hans and Willy. I also 
cannot express enough gratitude for my longest and closest friends who are 
teaching me great lessons simply by being themselves: Lynn, Julia, and 
Sadia. And, since I’m running out of space (and time and money), I’ll just 
name the rest: Ying, Brenda, Jeffrey, Wensheng, Agathe, Cindy, Natasha, 
Bin, Fred, Cathelijne, and Paul. 
Curriculum Vitae  167 
 
Curriculum Vitae 
The author of this thesis was born on 6 November 1975 just outside the 
town of Port Elgin, Ontario, Canada. Her childhood and adolescent years 
were spent in rural Ontario on a family farm. Here, her close contact with 
nature shaped a drive for self reflection and intellectual exploration, 
tempered by strong family values. After graduating from the local high 
school, Saugeen District Secondary School in 1994, she moved southward 
to pursue university education. Eventually, in 1999, she was awarded two 
concurrent degrees, the first, an Honours Bachelor of Science degree from 
the University of Waterloo and the second, a Bachelor of Education degree 
from Queen’s University. Her undergraduate years also brought her into 
contact with people from diverse cultures, leading her to befriend students 
from Europe and Asia, and ultimately allowing her to discover an 
extroverted side and to develop a passion for people. These experiences 
encouraged her to explore her Dutch roots, so when she was awarded a 
research grant in 1999 from Natural Science and Engineering Research 
Council of Canada (NSERC), she departed for the Netherlands to pursue a 
doctoral program at the University of Nijmegen, under the supervision of 
Dr. Geerten Vuister, Dr. Wiljan Hendriks and Prof. Dr. Kees Hilbers. 
by Julia Głowacka
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Once a human being has  
lost a hen or a dog, he knows  
where he can find it. But  
when he has lost  
his heart, he doesn’t know  
where to find it.  
The science of learning  
doesn’t follow any  
reason except to  
find the lost heart. 
 
MENCIUS 
